Genetic epidemiology of COPD (COPDGene) study design.
- Authors
- Regan, Elizabeth A; Hokanson, John E; Murphy, James R; Make, Barry; Lynch, David A; Beaty, Terri H; Curran-Everett, Douglas; Silverman, Edwin K; Crapo, James D
- Year
- 2010
- Journal
- COPD
- PMID
- 20214461
- DOI
- 10.3109/15412550903499522
- PMCID
- PMC2924193
BACKGROUND: COPDGene is a multicenter observational study designed to identify genetic factors associated with COPD. It will also characterize chest CT phenotypes in COPD subjects, including assessment of emphysema, gas trapping, and airway wall thickening. Finally, subtypes of COPD based on these phenotypes will be used in a comprehensive genome-wide study to identify COPD susceptibility genes. METHODS/RESULTS: COPDGene will enroll 10,000 smokers with and without COPD across the GOLD stages. Both Non-Hispanic white and African-American subjects are included in the cohort. Inspiratory and expiratory chest CT scans will be obtained on all participants. In addition to the cross-sectional enrollment process, these subjects will be followed regularly for longitudinal studies. A genome-wide association study (GWAS) will be done on an initial group of 4000 subjects to identify genetic variants associated with case-control status and several quantitative phenotypes related to COPD. The initial findings will be verified in an additional 2000 COPD cases and 2000 smoking control subjects, and further validation association studies will be carried out. CONCLUSIONS: COPDGene will provide important new information about genetic factors in COPD, and will characterize the disease process using high resolution CT scans. Understanding genetic factors and CT phenotypes that define COPD will potentially permit earlier diagnosis of this disease and may lead to the development of treatments to modify progression.
No figures extracted from this document.
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| A simple index for predicting mucus plugs in patients with chronic obstructive pulmonary disease. | Wang W et al. | โ | 2026 | โ |
| Beyond Triple Therapy: Anti-Type 2 Biologic Therapies for Eosinophilic COPD and Respiratory Comorbidities - a Review of Clinical Evidence. | Mari PV et al. | โ | 2026 | โ |
| Clinical Validation of a Multidimensional Diagnostic Approach for COPD in Chinese Individuals. | Wu F et al. | โ | 2026 | โ |
| Defining obstruction in COPD: do fixed ratio and lower limit of normal criteria reflect different clinical characteristics? findings from a Greek cross-sectional study (EMENO). | Gangadi ฮ et al. | โ | 2026 | โ |
| Elastic parametric response mapping: quantitative CT scoring for local COPD severity. | Labaki WW et al. | โ | 2026 | โ |
| Lower lobe mucus plug distribution and future respiratory exacerbations in tobacco-exposed individuals with and without COPD. | Wan ES et al. | โ | 2026 | โ |
| Mapping the trajectory from pre-COPD to COPD: predictive value of symptoms, imaging, and physiologic abnormalities. | Zhang N et al. | โ | 2026 | โ |
| Maternal smoking and CC-16: implications for lung development and COPD across the lifespan. | Rojas-Quintero J et al. | โ | 2026 | โ |
| Multi-ancestry genome-wide association study and meta-analysis of lung function decline. | Patchen BK et al. | โ | 2026 | โ |
| Nasal epithelium and blood transcriptomic signatures associations with smoking and exacerbations. | Tejwani V et al. | โ | 2026 | โ |
| Overlap between COPD genetic association results and transcriptional quantitative trait loci. | Saferali A et al. | โ | 2026 | โ |
| Preserved muscle oxidative capacity in COPD patients with hypoxemia treated by long term O<sub>2</sub> therapy. | Adami A et al. | โ | 2026 | โ |
| Pulmonary Obstruction and Age, Not Activity, Associate With Muscle Oxidative Impairment in Smokers With and Without COPD. | Adami A et al. | โ | 2026 | โ |
| Pulmonary vascular features on chest computed tomography differentially associate with adverse outcomes in smokers in COPDGene. | Johnson SW et al. | โ | 2026 | โ |
| Relationships between bronchodilator responsiveness, a COPD polygenic risk score, and COPD progression. | Fortis S et al. | โ | 2026 | โ |
| The Swedish CArdioPulmonary bioImage Study re-examination: Rationale, design, methods, and management of incidental findings. | Good E et al. | โ | 2026 | โ |
| A generalized higher-order correlation analysis framework for multi-omics network inference. | Liu W et al. | โ | 2025 | โ |
| Airway Mucus Plugs on Chest Computed Tomography Are Associated with Exacerbations in Chronic Obstructive Pulmonary Disease. | Wan E et al. | โ | 2025 | โ |
| A Multidimensional Diagnostic Approach for Chronic Obstructive Pulmonary Disease. | COPDGene 2025 Diagnosis Working Group and CanCOLD Investigators et al. | โ | 2025 | โ |
| Application of Artificial Intelligence in Thoracic Radiology: A Narrative Review. | Lim WH et al. | โ | 2025 | โ |
| Assessing inflammatory protein biomarkers in COPD subjects with and without alpha-1 antitrypsin deficiency. | Moll M et al. | โ | 2025 | โ |
| Assessment of the clinical prognosis of patients with chronic obstructive pulmonary disease using combined blood and sputum eosinophil counts. | Peng J et al. | โ | 2025 | โ |
| Association between automatic AI-based quantification of airway-occlusive mucus plugs and all-cause mortality in patients with COPD. | van der Veer T et al. | โ | 2025 | โ |
| Association of Lung Quantitative CT Scan Textures With Systemic Inflammation and Mortality in COPD. | Awan HA et al. | โ | 2025 | โ |
| Associations of Prepandemic Lung Function and Structure with COVID-19 Outcomes: The C4R Study. | Balte PP et al. | โ | 2025 | โ |
| A survey on deep learning for polygenic risk scores. | Schuran M et al. | โ | 2025 | โ |
| Automated CT-based decoupling of the effects of airway narrowing and wall thinning on airway counts in chronic obstructive pulmonary disease. | Nadeem SA et al. | โ | 2025 | โ |
| Automated CT-based measurements of radial and longitudinal expansion of airways due to breathing-related lung volume change. | Nadeem SA et al. | โ | 2025 | โ |
| B-cell immune repertoire sequencing in tobacco cigarette smoking, vaping, and chronic obstructive pulmonary disease in the COPDGene cohort. | Moll M et al. | โ | 2025 | โ |
| Beyond Obstruction-A Milestone in COPD Diagnosis. | Polverino F | โ | 2025 | โ |
| Classifying COVID-19 hospitalizations in epidemiology cohort studies: The C4R study. | Oelsner EC et al. | โ | 2025 | โ |
| Cluster analysis identifies quantitative CT imaging-based subgroups in COPD subjects with pulmonary artery enlargement. | Johnson SW et al. | โ | 2025 | โ |
| Comparison of quantitative lung measures in low dose energy-integrating detector and photon-counting detector chest CT with an anthropomorphic phantom. | AlArab N et al. | โ | 2025 | โ |
| Computed Tomography Radiomics Features Predict Change in Lung Density and Rate of Emphysema Progression. | Saha P et al. | โ | 2025 | โ |
| CT-based airway changes after smoking cessation in the general population. | Dudurych I et al. | โ | 2025 | โ |
| CT-derived functional imaging biomarkers combined with FEV1 for predicting 10-year all-cause mortality in COPDGene cohort. | Nair G et al. | โ | 2025 | โ |
| CURE Asthma: a unique opportunity for Australia. | Flynn A et al. | โ | 2025 | โ |
| Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA). | Klopack ET et al. | โ | 2025 | โ |
| Effect of Common Medications on Longitudinal Pectoralis Muscle Area in Smokers. | Shirahata T et al. | โ | 2025 | โ |
| Effect of High Altitude on Small Pulmonary Vein and Artery Volume in the COPDGene Cohort: Towards Better Understanding of Lung Physiology and Pulmonary Disease. | Kwee AKAL et al. | โ | 2025 | โ |
| Effect of inspiratory lung volume on bronchial and arterial dimensions and ratios on chest computed tomography in patients with chronic obstructive pulmonary disease. | Chen Y et al. | โ | 2025 | โ |
| Effect of slice thickness on quantitative analysis of interstitial lung disease: a retrospective volumetric chest CT study. | Puลกeljiฤ M et al. | โ | 2025 | โ |
| Emphysema progression risk in COPD using a localized foundational model of density evolution. | Curiale AH et al. | โ | 2025 | โ |
| Expiration CT Gas Trapping Measures with Texture-Based Radiomics Improves Association with Lung Function and Lung Function Decline in COPD. | Koo MC et al. | โ | 2025 | โ |
| Extensions of Heterogeneity in Integration and Prediction (HIP) With R Shiny Application. | Butts J et al. | โ | 2025 | โ |
| Factors associated with new onset of depression and anxiety symptoms differ by sex in the COPDGene study. | Voorhies K et al. | โ | 2025 | โ |
| Frailty associates with respiratory exacerbations and mortality in the COPDGene cohort. | Phillips EK et al. | โ | 2025 | โ |
| Genetic resilience to chronic obstructive pulmonary disease is a clinically distinct subtype in individuals with cigarette smoke exposure. | Ghosh AJ et al. | โ | 2025 | โ |
| Genomic and phenotypic correlates of mosaic loss of chromosome Y in blood. | Jakubek YA et al. | โ | 2025 | โ |
| Genomic and Serological Rheumatoid Arthritis Biomarkers, <i>MUC5B</i> Promoter Variant, and Interstitial Lung Abnormalities. | Kim JS et al. | โ | 2025 | โ |
| GOLD grade-specific characterization of COPD in the COSYCONET multi-center trial: comparison of semiquantitative MRI and quantitative CT. | Konietzke P et al. | โ | 2025 | โ |
| GOLD-Grade Specific Disease Characterization and Phenotyping of COPD Using Quantitative Computed Tomography in the Nationwide COSYCONET Multicenter Trial in Germany. | Konietzke P et al. | โ | 2025 | โ |
| Hair follicle gene expression profiling in the SubPopulations and InteRmediate Outcome Measures in COPD Study (SPIROMICS). | Buschur KL et al. | โ | 2025 | โ |
| Harmonized low-dose computed tomographic protocols for quantitative lung imaging using dose modulation and advanced reconstructions. | Atha J et al. | โ | 2025 | โ |
| High-dimensional causal mediation analysis by partial sum statistic and sample splitting strategy in imaging genetics application. | Chang HC et al. | โ | 2025 | โ |
| Identifying chronic obstructive pulmonary disease subtypes using multi-trait genetics. | Ziyatdinov A et al. | โ | 2025 | โ |
| Impact of cigarette smoke on pulmonary vein and artery volumes in those with current and former smoking status: a quantitative computed tomography analysis. | Kwee AKAL et al. | โ | 2025 | โ |
| Impact of the CAPTURE Chronic Obstructive Pulmonary Disease Screening Tool in U.S. Primary Care: A Cluster-Randomized Trial. | Martinez FJ et al. | โ | 2025 | โ |
| Interstitial lung abnormalities, coronary heart disease and mortality. | Cutting CC et al. | โ | 2025 | โ |
| Intra- and inter-scanner CT variability and their impact on diagnostic tasks. | Montero I et al. | โ | 2025 | โ |
| Investigating the impact of kernel harmonization and deformable registration on inspiratory and expiratory chest CT images for people with COPD. | Krishnan AR et al. | โ | 2025 | โ |
| Longitudinal Changes in Airway Mucus Plugs and FEV<sub>1</sub> in COPD. | Mettler SK et al. | โ | 2025 | โ |
| Longitudinal study of COPD phenotypes using integrated SPECT and qCT imaging. | Li F et al. | โ | 2025 | โ |
| Lung Transcriptomics Link Emphysema to Barrier Dysfunction and Macrophage Subpopulations. | Lu R et al. | โ | 2025 | โ |
| Mechanically Affected Lung and Progression of Emphysema. | Bhatt SP et al. | โ | 2025 | โ |
| Molecular determinants of lung function decline: a multi-level analysis of gene expression. | Elhusseini ZW et al. | โ | 2025 | โ |
| Navigating the Progression of Chronic Obstructive Pulmonary Disease. | Pistenmaa C et al. | โ | 2025 | โ |
| Novel Lobe-based Transformer model (LobTe) to predict emphysema progression in Alpha-1 Antitrypsin Deficiency. | Curiale AH et al. | โ | 2025 | โ |
| Novel risk loci encompassing genes influencing STAT3, GPCR, and oxidative stress signaling are associated with co-morbid GERD and COPD. | Wilson AC et al. | โ | 2025 | โ |
| Optimizing convolutional neural networks for Chronic Obstructive Pulmonary Disease detection in clinical computed tomography imaging. | Dorosti T et al. | โ | 2025 | โ |
| Oxidative Stress and Inflammation in Hypoxemic Respiratory Diseases and Their Comorbidities: Molecular Insights and Diagnostic Advances in Chronic Obstructive Pulmonary Disease and Sleep Apnea. | Rodrรญguez-Pรฉrez J et al. | โ | 2025 | โ |
| Peripheral blood miRNAs are associated with airflow below threshold in children with asthma. | Tiwari A et al. | โ | 2025 | โ |
| Polygenic Risk Score Added to Conventional Case Finding to Identify Undiagnosed Chronic Obstructive Pulmonary Disease. | Zhang J et al. | โ | 2025 | โ |
| Polygenic risk scores for rheumatoid arthritis and idiopathic pulmonary fibrosis and associations with RA, interstitial lung abnormalities, and quantitative interstitial abnormalities among smokers. | McDermott GC et al. | โ | 2025 | โ |
| Proteomic biomarkers of emphysema-predominant and non-emphysema-predominant chronic obstructive pulmonary disease. | Zhang YH et al. | โ | 2025 | โ |
| Proteomic discovery analysis of quantitatively assessed emphysema in the general population. The MESA Lung Study. | Guzman DE et al. | โ | 2025 | โ |
| Quantitative Accuracy of CT Protocols for Cross-sectional and Longitudinal Assessment of COPD: A Virtual Imaging Study. | Bhattarai M et al. | โ | 2025 | โ |
| Quantitative CT Imaging Features Associated with Stable PRISm using Machine Learning. | Lukhumaidze L et al. | โ | 2025 | โ |
| Race, Environmental Exposures, and Interstitial Lung Abnormalities. | Tukpah AC et al. | โ | 2025 | โ |
| Rationale and Design of the Alpha-1 Biomarkers Consortium Study. | Goldklang MP et al. | โ | 2025 | โ |
| Respiratory Exacerbations and Lung Function Decline in People with Smoking History and Normal Spirometry. | Fortis S et al. | โ | 2025 | โ |
| Rheumatoid arthritis, quantitative parenchymal lung features and mortality among smokers. | McDermott GC et al. | โ | 2025 | โ |
| Seeing is Believing-On the Utility of CT in Phenotyping COPD. | Awan HA et al. | โ | 2025 | โ |
| Self-Reported Resilience During the COVID-19 Pandemic. | Ogungbe O et al. | โ | 2025 | โ |
| Temporal Exploration of Chronic Obstructive Pulmonary Disease Phenotypes: Insights from the COPDGene and SPIROMICS Cohorts. | Bell AJ et al. | โ | 2025 | โ |
| The Calprotectin Fragment, CPa9-HNE, Is a Plasma Biomarker of Mild Chronic Obstructive Pulmonary Disease. | Joglekar MM et al. | โ | 2025 | โ |
| The Need for Biomarkers Common to Blood and Lung Tissue in Emphysema: Anyone Would Rather Give You a Blood Sample than a Lung Sample. | McDonald MN | โ | 2025 | โ |
| TriSwinUNETR lobe segmentation model for computing DIR-free CT-ventilation. | Nomura GRO et al. | โ | 2025 | โ |
| Uncertainty-aware quantitative CT evaluation of emphysema and mortality risk from variable radiation dose images. | Baraghoshi D et al. | โ | 2025 | โ |
| Visual and Quantitative Interstitial Lung Abnormality Progression in COPDGene. | Putman RK et al. | โ | 2025 | โ |
| Vitamin D Supplementation, Chronic Obstructive Lung Disease and Asthma Exacerbations, and Lung Function Decline. | Gold DR et al. | โ | 2025 | โ |
| A Deep Learning-Based Radiomic Classifier for Usual Interstitial Pneumonia. | Chung JH et al. | โ | 2024 | โ |
| A fully automated pipeline for the extraction of pectoralis muscle area from chest computed tomography scans. | Genkin D et al. | โ | 2024 | โ |
| Airway-occluding Mucus Plugs and Cause-specific Mortality in Chronic Obstructive Pulmonary Disease. | Mettler SK et al. | โ | 2024 | โ |
| Airway tapering in COPD. | Bodduluri S et al. | โ | 2024 | โ |
| An integrative network-based approach to identify driving gene communities in chronic obstructive pulmonary disease. | Marino R et al. | โ | 2024 | โ |
| A novel application of data-consistent inversion to overcome spurious inference in genome-wide association studies. | Janani N et al. | โ | 2024 | โ |
| A novel phenotype imputation method with copula model. | Zhang J et al. | โ | 2024 | โ |
| A Physics-Informed Deep Neural Network for Harmonization of CT Images. | Zarei M et al. | โ | 2024 | โ |
| Application of the European Respiratory Society/American Thoracic Society Spirometry Standards and Race-Neutral Equations in the COPDGene Study. | Schiavi E et al. | โ | 2024 | โ |
| A protein risk score for all-cause and respiratory-specific mortality in non-Hispanic white and African American individuals who smoke. | Moll M et al. | โ | 2024 | โ |
| Artificial Intelligence in Chronic Obstructive Pulmonary Disease: Research Status, Trends, and Future Directionsย --A Bibliometric Analysis from 2009 to 2023. | Bian H et al. | โ | 2024 | โ |
| Artificial intelligence in COPD CT images: identification, staging, and quantitation. | Wu Y et al. | โ | 2024 | โ |
| Assessment of Pulmonary Ventilation Using 3D Ventilation Flow Capacity-Weighted and Ventilation-Weighted Maps From 3D Ultrashort Echo Time (UTE) MRI. | Lee S et al. | โ | 2024 | โ |
| Association of Acute Respiratory Disease Events with Quantitative Interstitial Abnormality Progression at CT in Individuals with a History of Smoking. | Choi B et al. | โ | 2024 | โ |
| Association of blood eosinophils with corticosteroid treatment failure stratified by smoking status among inpatients with AECOPD. | Li J et al. | โ | 2024 | โ |
| Association of <i>PHACTR1</i> with Coronary Artery Calcium Differs by Sex and Cigarette Smoking. | Voorhies K et al. | โ | 2024 | โ |
| A systematic assessment and optimization of photon-counting CT for lung density quantifications. | Sotoudeh-Paima S et al. | โ | 2024 | โ |
| Automated evaluation of diaphragm configuration based on chest CT in COPD patients. | Bakker JT et al. | โ | 2024 | โ |
| Blood-based Transcriptomic and Proteomic Biomarkers of Emphysema. | Suryadevara R et al. | โ | 2024 | โ |
| Causal inference analysis of the radiologic progression in the chronic obstructive pulmonary disease. | Im Y et al. | โ | 2024 | โ |
| Chest CT-based automated vertebral fracture assessment using artificial intelligence and morphologic features. | Nadeem SA et al. | โ | 2024 | โ |
| Chronic Obstructive Pulmonary Disease Exacerbations Increase the Risk of Subsequent Cardiovascular Events: A Longitudinal Analysis of the COPDGene Study. | Yang HM et al. | โ | 2024 | โ |
| Clinical significance of chronic bronchitis in different racial groups. | Choi JY et al. | โ | 2024 | โ |
| CT strain metrics allow for earlier diagnosis of bronchiolitis obliterans syndrome after hematopoietic cell transplant. | Sharifi H et al. | โ | 2024 | โ |
| Design of the SPIROMICS Study of Early COPD Progression: SOURCE Study. | Curtis JL et al. | โ | 2024 | โ |
| Development and Application of a Virtual Imaging Trial Framework for Longitudinal Quantification of Emphysema in CT. | Sotoudeh-Paima S et al. | โ | 2024 | โ |
| Development and validation of a mortality risk prediction model for chronic obstructive pulmonary disease: a cross-sectional study using probabilistic graphical modelling. | Lovelace TC et al. | โ | 2024 | โ |
| Development, Progression, and Mortality of Suspected Interstitial Lung Disease in COPDGene. | Rose JA et al. | โ | 2024 | โ |
| Differential Association of COPD Subtypes With Cardiovascular Events and COPD Exacerbations. | Yang HM et al. | โ | 2024 | โ |
| Distinct physiological, transcriptomic, and imaging characteristics of asthma-COPD overlap compared to asthma and COPD in smokers. | Fangal VD et al. | โ | 2024 | โ |
| DrasCLR: A self-supervised framework of learning disease-related and anatomy-specific representation for 3D lung CT images. | Yu K et al. | โ | 2024 | โ |
| Dysanapsis is differentially related to lung function trajectories with distinct structural and functional patterns in COPD and variable risk for adverse outcomes. | Ross JC et al. | โ | 2024 | โ |
| Early Evidence of Chronic Obstructive Pulmonary Disease Obscured by Race-Specific Prediction Equations. | Regan EA et al. | โ | 2024 | โ |
| Endotypes of Paediatric Cough-Do They Exist and Finding New Techniques to Improve Clinical Outcomes. | O'Farrell HE et al. | โ | 2024 | โ |
| Epidemiologic Features of Recovery From SARS-CoV-2 Infection. | Oelsner EC et al. | โ | 2024 | โ |
| Estimating effects of aging and disease progression in current and former smokers using longitudinal models. | Strand M et al. | โ | 2024 | โ |
| Estimating lung function from computed tomography at the patient and lobe level using machine learning. | Boulogne LH et al. | โ | 2024 | โ |
| Evaluating the Cumulative Benefit of Inspiratory CT, Expiratory CT, and Clinical Data for COPD Diagnosis and Staging through Deep Learning. | Lee AN et al. | โ | 2024 | โ |
| Examining the Effect of Genes on Depression as Mediated by Smoking and Modified by Sex. | Voorhies K et al. | โ | 2024 | โ |
| Expiratory Venous Volume and Arterial Tortuosity are Associated with Disease Severity and Mortality Risk in Patients with COPD: Results from COSYCONET. | Stoleriu MG et al. | โ | 2024 | โ |
| Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease. | Zhang J et al. | โ | 2024 | โ |
| Genetics of chronic respiratory disease. | Sayers I et al. | โ | 2024 | โ |
| Higher small pulmonary artery and vein volume on computed tomography is associated with mortality in current and former smokers. | Kwee AKAL et al. | โ | 2024 | โ |
| HIP: a method for high-dimensional multi-view data integration and prediction accounting for subgroup heterogeneity. | Butts J et al. | โ | 2024 | โ |
| How do deep-learning models generalize across populations? Cross-ethnicity generalization of COPD detection. | D Almeida S et al. | โ | 2024 | โ |
| Identification of factors directly linked to incident chronic obstructive pulmonary disease: A causal graph modeling study. | Gregg RW et al. | โ | 2024 | โ |
| Impact of Applying the Global Lung Initiative Criteria for Airway Obstruction in GOLD Defined COPD Cohorts: The BODE and CHAIN Experience. | de-Torres JP et al. | โ | 2024 | โ |
| Impact of Smoking and Chronic Obstructive Pulmonary Disease on All-Cause, Respiratory, and Cardio-Cerebrovascular Mortality. | Kang HR et al. | โ | 2024 | โ |
| Impact of the COVID-19 Pandemic on Outcomes of CAPTURE: A Primary Care Chronic Obstructive Pulmonary Disease Screening Clinical Trial. | Yawn BP et al. | โ | 2024 | โ |
| Is Smoked Marijuana a Risk Factor for Chronic Obstructive Pulmonary Disease? An Enduring Controversy. | Tashkin DP | โ | 2024 | โ |
| Local heterogeneity of normal lung parenchyma and small airways disease are associated with COPD severity and progression. | Bell AJ et al. | โ | 2024 | โ |
| LungViT: Ensembling Cascade of Texture Sensitive Hierarchical Vision Transformers for Cross-Volume Chest CT Image-to-Image Translation. | Chaudhary MFA et al. | โ | 2024 | โ |
| Metabolic Aging as an Increased Risk for Chronic Obstructive Pulmonary Disease. | Guo CJ et al. | โ | 2024 | โ |
| PathIntegrate: Multivariate modelling approaches for pathway-based multi-omics data integration. | Wieder C et al. | โ | 2024 | โ |
| Phenotyping of COPD with MRI in comparison to same-day CT in a multi-centre trial. | Nauck S et al. | โ | 2024 | โ |
| PiSlope: A New CT Metric for Quantifying Airway Remodeling in Chronic Obstructive Pulmonary Disease. | Bhatt SP et al. | โ | 2024 | โ |
| Polygenic and transcriptional risk scores identify chronic obstructive pulmonary disease subtypes in the COPDGene and ECLIPSE cohort studies. | Moll M et al. | โ | 2024 | โ |
| Preacinar Arterial Dilation Mediates Outcomes of Quantitative Interstitial Abnormalities in the COPDGene Study. | Harder EM et al. | โ | 2024 | โ |
| Prediction of disease severity in COPD: a deep learning approach for anomaly-based quantitative assessment of chest CT. | Almeida SD et al. | โ | 2024 | โ |
| Proteomic networks and related genetic variants associated with smoking and chronic obstructive pulmonary disease. | Konigsberg IR et al. | โ | 2024 | โ |
| Proteomics and machine learning in the prediction and explanation of low pectoralis muscle area. | Enzer NA et al. | โ | 2024 | โ |
| Quantification of Emphysema Progression at CT Using Simultaneous Volume, Noise, and Bias Lung Density Correction. | Vegas Sรกnchez-Ferrero G et al. | โ | 2024 | โ |
| R2C2 + UMI: Combining concatemeric and unique molecular identifier-based consensus sequencing enables ultra-accurate sequencing of amplicons on Oxford Nanopore Technologies sequencers. | Deng DZQ et al. | โ | 2024 | โ |
| Race Adjustment of Pulmonary Function Tests in the Diagnosis and Management of COPD: A Scoping Review. | Davidson SR et al. | โ | 2024 | โ |
| Relationship Between Tobacco Product Use and Health-Related Quality of Life Among Individuals With COPD in Waves 1-5 (2013-2019) of the Population Assessment of Tobacco and Health Study. | Paulin LM et al. | โ | 2024 | โ |
| Reply to Verbanck and Vanderhelst: Toward Realistic Longitudinal Monitoring of Structure?Function in Smokers. | Ritchie AI et al. | โ | 2024 | โ |
| Rheumatoid arthritis and changes on spirometry by smoking status in two prospective longitudinal cohorts. | Hayashi K et al. | โ | 2024 | โ |
| Risk Factors for Chronic Obstructive Pulmonary Disease Exacerbations among Individuals without a History of Recent Exacerbations: A COPDGene Analysis. | Ferrera MC et al. | โ | 2024 | โ |
| Self-report underestimates the frequency of the acute respiratory exacerbations of COPD but is associated with BAL neutrophilia and lymphocytosis: an observational study. | Abrham Y et al. | โ | 2024 | โ |
| Self-supervised learning framework application for medical image analysis: a review and summary. | Zeng X et al. | โ | 2024 | โ |
| Silent Airway Mucus Plugs in COPD and Clinical Implications. | Mettler SK et al. | โ | 2024 | โ |
| STAR Has Better Discrimination for Mortality than ERS/ATS Chronic Obstructive Pulmonary Disease Severity Classification. | Bhatt SP et al. | โ | 2024 | โ |
| The COPD Foundation on Its Twentieth Anniversary. | Malanga E et al. | โ | 2024 | โ |
| The Natural History of Severe Chronic Obstructive Pulmonary Disease: The SPOCCAT Study Protocol. | Gonzรกlez J et al. | โ | 2024 | โ |
| The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease. | Burkes RM et al. | โ | 2024 | โ |
| Topologic Parametric Response Mapping Identifies Tissue Subtypes Associated with Emphysema Progression. | Wang JM et al. | โ | 2024 | โ |
| Type 2 Inflammation Is Associated with Emphysema on Computed Tomography. | Bhatt SP et al. | โ | 2024 | โ |
| Ultra-low dose hip CT-based automated measurement of volumetric bone mineral density at proximal femoral subregions. | Zhang X et al. | โ | 2024 | โ |
| Uncovering early COPD? The T-slope as a novel CT biomarker for evaluating airway narrowing. | Kirby M et al. | โ | 2024 | โ |
| Understanding the Added Value of High-Resolution CT Beyond Chest X-Ray in Determining Extent of Physiologic Impairment. | Benn BS et al. | โ | 2024 | โ |
| Unsupervised representation learning on high-dimensional clinical data improves genomic discovery and prediction. | Yun T et al. | โ | 2024 | โ |
| Utility of block-matching and 3D filter for reproducibility of lung density and denoising in low-dose chest CT: A pilot study. | Shim J et al. | โ | 2024 | โ |
| Utility of peripheral protein biomarkers for the prediction of incident interstitial features: a multicentre retrospective cohort study. | Ash S et al. | โ | 2024 | โ |
| Validation of Systemic Complement Signatures in the Progression of Chronic Obstructive Pulmonary Disease. | DiLillo KM et al. | โ | 2024 | โ |
| Airway-Occluding Mucus Plugs and Mortality in Patients With Chronic Obstructive Pulmonary Disease. | Diaz AA et al. | โ | 2023 | โ |
| Alpha-1 antitrypsin inhibits fractalkine-mediated monocyte-lung endothelial cell interactions. | Mikosz A et al. | โ | 2023 | โ |
| A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities. | Moll M et al. | โ | 2023 | โ |
| Artificial Intelligence-based CT Assessment of Bronchiectasis: The COPDGene Study. | Dรญaz AA et al. | โ | 2023 | โ |
| Associations Between Muscle Weakness and Clinical Outcomes in Current and Former Smokers. | Zou RH et al. | โ | 2023 | โ |
| A Survey on Artificial Intelligence in Pulmonary Imaging. | Saha PK et al. | โ | 2023 | โ |
| Automated detection of airflow obstructive diseases: A systematic review of the last decade (2013-2022). | Xu S et al. | โ | 2023 | โ |
| Baseline characteristics from a 3-year longitudinal study to phenotype subjects with COPD: the FOOTPRINTS study. | Crapo JD et al. | โ | 2023 | โ |
| Bik promotes proteasomal degradation to control low-grade inflammation. | Mebratu YA et al. | โ | 2023 | โ |
| Bilirubin-associated single nucleotide polymorphism (SNP) and respiratory health outcomes: a mendelian randomization study. | Baldomero AK et al. | โ | 2023 | โ |
| Blood Gene Expression and Immune Cell Subtypes Associated with Chronic Obstructive Pulmonary Disease Exacerbations. | Ryu MH et al. | โ | 2023 | โ |
| Cascading Affine and B-spline Registration Method for Large Deformation Registration of Lung X-rays. | Chang Q et al. | โ | 2023 | โ |
| Causes of and Clinical Features Associated with Death in Tobacco Cigarette Users by Lung Function Impairment. | Labaki WW et al. | โ | 2023 | โ |
| Chest MRI and CT Predictors of 10-Year All-Cause Mortality in COPD. | Sharma M et al. | โ | 2023 | โ |
| Cigarette smoking and disproportionate changes of thoracic skeletal muscles in low-dose chest computed tomography. | Lim WH et al. | โ | 2023 | โ |
| Clinical Markers Associated With Risk of Suicide or Drug Overdose Among Individuals Withย Smoking Exposure: A Longitudinal Follow-up Study of the COPDGene Cohort. | Adviento BA et al. | โ | 2023 | โ |
| Continuum finite element analysis generalizes<i>in vivo</i>trabecular bone microstructural strength measures between two CT scanners with different image resolution. | Guha I et al. | โ | 2023 | โ |
| Deep Learning Assessment of Progression of Emphysema and Fibrotic Interstitial Lung Abnormality. | Ash SY et al. | โ | 2023 | โ |
| Deep Learning Integration of Chest Computed Tomography Imaging and Gene Expression Identifies Novel Aspects of COPD. | Chen J et al. | โ | 2023 | โ |
| Deep learning on graphs for multi-omics classification of COPD. | Zhuang Y et al. | โ | 2023 | โ |
| Diffusing Capacity and Mortality in Chronic Obstructive Pulmonary Disease. | Balasubramanian A et al. | โ | 2023 | โ |
| Direct estimation of regional lung volume change from paired and single CT images using residual regression neural network. | Gerard SE et al. | โ | 2023 | โ |
| Discriminative Accuracy of the CAPTURE Tool for Identifying Chronic Obstructive Pulmonary Disease in US Primary Care Settings. | Martinez FJ et al. | โ | 2023 | โ |
| Electronic cigarette menthol flavoring is associated with increased inhaled micro and sub-micron particles and worse lung function in combustion cigarette smokers. | Chandra D et al. | โ | 2023 | โ |
| Emphysema subtyping on thoracic computed tomography scans using deep neural networks. | Xie W et al. | โ | 2023 | โ |
| Evaluation of graphical models for multi-group metabolomics data. | Zhao H et al. | โ | 2023 | โ |
| FEV<sub>1</sub>/FVC Severity Stages for Chronic Obstructive Pulmonary Disease. | Bhatt SP et al. | โ | 2023 | โ |
| Findings on High Resolution Computed Tomography in Symptomatic Veterans with Deployment-Related Lung Disease. | Rose CS et al. | โ | 2023 | โ |
| Flow-Volume Curve Patterns in Radiologic Expiratory Central Airway Collapse. | Kalehoff JP et al. | โ | 2023 | โ |
| From pre-COPD to COPD: a Simple, Low cost and easy to IMplement (SLIM) risk calculator. | Divo MJ et al. | โ | 2023 | โ |
| Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes. | Van Buren E et al. | โ | 2023 | โ |
| Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease. | Chen Y et al. | โ | 2023 | โ |
| GradICON: Approximate Diffeomorphisms via Gradient Inverse Consistency. | Tian L et al. | โ | 2023 | โ |
| Hepatitis C and HIV detection by blood RNA-sequencing in cohort of smokers. | Morrow JD et al. | โ | 2023 | โ |
| Heterogeneity and Progression of Chronic Obstructive Pulmonary Disease: Emphysema-Predominant and Non-Emphysema-Predominant Disease. | Castaldi PJ et al. | โ | 2023 | โ |
| Hierarchical association of COPD to principal genetic components of biological systems. | Carlin DE et al. | โ | 2023 | โ |
| Idiopathic pulmonary fibrosis is more strongly associated with coronary artery disease than chronic obstructive pulmonary disease. | Bray K et al. | โ | 2023 | โ |
| Impact of Interstitial Lung Abnormalities on Disease Expression and Outcomes in COPD or Emphysema: A Systematic Review. | Liu Y et al. | โ | 2023 | โ |
| Influence of Pulsatility and Inflow Waveforms on Tracheal Airflow Dynamics in Healthy Older Adults. | Tiwari B et al. | โ | 2023 | โ |
| Large scale proteomic studies create novel privacy considerations. | Hill AC et al. | โ | 2023 | โ |
| LEF1 isoforms regulate cellular senescence and aging. | Jia M et al. | โ | 2023 | โ |
| Longitudinal Assessment of Multimorbidity Medication Patterns among Smokers in the COPDGene Cohort. | Li Y et al. | โ | 2023 | โ |
| Lung volumes differentiate the predominance of emphysema <i>versus</i> airway disease phenotype in early COPD: an observational study of the COPDGene cohort. | Zeng S et al. | โ | 2023 | โ |
| Machine learning and deep learning predictive models for long-term prognosis in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. | Smith LA et al. | โ | 2023 | โ |
| Machine learning for screening of at-risk, mild and moderate COPD patients at risk of FEV<sub>1</sub> decline: results from COPDGene and SPIROMICS. | Wang JM et al. | โ | 2023 | โ |
| Metabolomics in COPD. | Gea J et al. | โ | 2023 | โ |
| Mosaic chromosomal alterations in blood across ancestries using whole-genome sequencing. | Jakubek YA et al. | โ | 2023 | โ |
| Multi-site, Multi-domain Airway Tree Modeling. | Zhang M et al. | โ | 2023 | โ |
| Networks as Biomarkers: Uses and Purposes. | Alfano C et al. | โ | 2023 | โ |
| Optimal Threshold of FEV<sub>t</sub>/FVC Ratio for Detection of Airflow Limitation Associated with Structural Lung Disease. | Bhatt SP et al. | โ | 2023 | โ |
| Parameter D: New Measure of Airflow Obstruction. | Bhatt SP et al. | โ | 2023 | โ |
| Plasma metabolomics and quantitative interstitial abnormalities in ever-smokers. | Choi B et al. | โ | 2023 | โ |
| Polygenic risk scores identify heterogeneity in asthma and chronic obstructive pulmonary disease. | Moll M et al. | โ | 2023 | โ |
| Predicting severe chronic obstructive pulmonary disease exacerbations using quantitative CT: a retrospective model development and external validation study. | Chaudhary MFA et al. | โ | 2023 | โ |
| Prevalence and mortality associations of interstitial lung abnormalities in rheumatoid arthritis within a multicentre prospective cohort of smokers. | McDermott GC et al. | โ | 2023 | โ |
| Prevalence of abnormal spirometry in individuals with a smoking history and no known obstructive lung disease. | Tran TV et al. | โ | 2023 | โ |
| Principal component analysis of flow-volume curves in COPDGene to link spirometry with phenotypes of COPD. | Verstraete K et al. | โ | 2023 | โ |
| Pulmonary emphysema subtypes defined by unsupervised machine learning on CT scans. | Angelini ED et al. | โ | 2023 | โ |
| Quantifying the spatial clustering characteristics of radiographic emphysema explains variability in pulmonary function. | Vestal BE et al. | โ | 2023 | โ |
| QUANTITATIVE BIOMARKERS REPRODUCIBILITY USING GENERATIVE ADVERSARIAL APPROACHES IN REDUCED TO CONVENTIONAL DOSE CT. | Nardelli P et al. | โ | 2023 | โ |
| Quantitative CT Analysis Based on Smoking Habits and Chronic Obstructive Pulmonary Disease in Patients with Normal Chest CT. | Byon JH et al. | โ | 2023 | โ |
| Quantitative CT Evaluation of Emphysema Progression over 10 Years in the COPDGene Study. | Baraghoshi D et al. | โ | 2023 | โ |
| Quantitative Interstitial Abnormality Progression and Outcomes in the Genetic Epidemiology of COPD and Pittsburgh Lung Screening Study Cohorts. | Choi B et al. | โ | 2023 | โ |
| Race-Specific Spirometry Equations Do Not Improve Models of Dyspnea and Quantitative Chest CT Phenotypes. | Non AL et al. | โ | 2023 | โ |
| Radiomics for Improved Detection of Chronic Obstructive Pulmonary Disease in Low-Dose and Standard-Dose Chest CT Scans. | Amudala Puchakayala PR et al. | โ | 2023 | โ |
| Repeatability of Pulmonary Quantitative Computed Tomography Measurements in Chronic Obstructive Pulmonary Disease. | Motahari A et al. | โ | 2023 | โ |
| Residual Volume versus FRC Computed Tomography Assessment of Functional Small Airway Disease in Smokers with and without Chronic Obstructive Pulmonary Disease. | Comellas AP et al. | โ | 2023 | โ |
| Returning incidentally discovered Hepatitis C RNA-seq results to COPDGene study participants. | Silverman EK et al. | โ | 2023 | โ |
| Risk Stratifying Interstitial Lung Abnormalities to Guide Early Diagnosis of Interstitial Lung Diseases. | Wijsenbeek MS et al. | โ | 2023 | โ |
| Single Modality vs. Multimodality: What Works Best for Lung Cancer Screening? | Sousa JV et al. | โ | 2023 | โ |
| Suspected Bronchiectasis and Mortality in Adults With a History of Smoking Who Have Normal and Impaired Lung Function : A Cohort Study. | Diaz AA et al. | โ | 2023 | โ |
| Suspected Interstitial Lung Disease in COPDGene Study. | Rose JA et al. | โ | 2023 | โ |
| The Promise of Quantitative Computed Tomographic Analysis in Assessing Progression of Interstitial Lung Abnormalities and Emphysema in Smokers. | Larici AR et al. | โ | 2023 | โ |
| The utility of quantitative computed tomography in cohort studies of chronic obstructive pulmonary disease: a narrative review. | Dai Q et al. | โ | 2023 | โ |
| TreeKernel: interpretable kernel machine tests for interactions between -omics and clinical predictors with applications to metabolomics and COPD phenotypes. | Carpenter CM et al. | โ | 2023 | โ |
| Understanding COPD Etiology, Pathophysiology, and Definition. | Curtis JL | โ | 2023 | โ |
| Unsupervised representation learning improves genomic discovery and risk prediction for respiratory and circulatory functions and diseases | Yun T et al. | โ | 2023 | โ |
| Update on metabolomic findings in COPD patients. | Gea J et al. | โ | 2023 | โ |
| Use of the Spirometric "Fixed-Ratio" Underdiagnoses COPD in African-Americans in a Longitudinal Cohort Study. | Regan EA et al. | โ | 2023 | โ |
| X chromosome associations with chronic obstructive pulmonary disease and related phenotypes: an X chromosome-wide association study. | Hayden LP et al. | โ | 2023 | โ |
| 10-Year Follow-Up of Lung Function, Respiratory Symptoms, and Functional Capacity in the COPDGene Study. | Ragland MF et al. | โ | 2022 | โ |
| A computationally efficient clustering linear combination approach to jointly analyze multiple phenotypes for GWAS. | Wang M et al. | โ | 2022 | โ |
| Acute Exacerbations Are Associated with Progression of Emphysema. | Bhatt SP et al. | โ | 2022 | โ |
| A genome-wide association study of bronchodilator response in participants of European and African ancestry from six independent cohorts. | Gereige JD et al. | โ | 2022 | โ |
| Airway Detection in COPD at Low-Dose CT Using Deep Learning and Multiparametric Freeze and Grow. | Nadeem SA et al. | โ | 2022 | โ |
| Alpha-1 Antitrypsin MZ Heterozygosity Is an Endotype of Chronic Obstructive Pulmonary Disease. | Ghosh AJ et al. | โ | 2022 | โ |
| A Metabolomic Severity Score for Airflow Obstruction and Emphysema. | Godbole S et al. | โ | 2022 | โ |
| An interferon-inducible signature of airway disease from blood gene expression profiling. | Yun JH et al. | โ | 2022 | โ |
| A polygenic risk score and age of diagnosis of COPD. | Zhang J et al. | โ | 2022 | โ |
| A review of deep learning-based deformable medical image registration. | Zou J et al. | โ | 2022 | โ |
| Artificial Intelligence for Interstitial Lung Disease Analysis on Chest Computed Tomography: A Systematic Review. | Soffer S et al. | โ | 2022 | โ |
| A Smoothed Version of the Lassosum Penalty for Fitting Integrated Risk Models Using Summary Statistics or Individual-Level Data. | Hahn G et al. | โ | 2022 | โ |
| Association of body mass index and COPD exacerbation among patients with chronic bronchitis. | Shin SH et al. | โ | 2022 | โ |
| Association of clonal hematopoiesis with chronic obstructive pulmonary disease. | Miller PG et al. | โ | 2022 | โ |
| Association of tobacco product use with chronic obstructive pulmonary disease (COPD) prevalence and incidence in Waves 1 through 5 (2013-2019) of the Population Assessment of Tobacco and Health (PATH) Study. | Paulin LM et al. | โ | 2022 | โ |
| Associations of Monocyte Count and Other Immune Cell Types with Interstitial Lung Abnormalities. | Kim JS et al. | โ | 2022 | โ |
| A statistical physics approach for disease module detection. | Wang XW et al. | โ | 2022 | โ |
| Automated estimation of total lung volume using chest radiographs and deep learning. | Sogancioglu E et al. | โ | 2022 | โ |
| Blood gene expression risk profiles and interstitial lung abnormalities: COPDGene and ECLIPSE cohort studies. | Moll M et al. | โ | 2022 | โ |
| Blood miRNAs Are Linked to Frequent Asthma Exacerbations in Childhood Asthma and Adult COPD. | Tiwari A et al. | โ | 2022 | โ |
| Blood RNA sequencing shows overlapping gene expression across COPD phenotype domains. | Ghosh AJ et al. | โ | 2022 | โ |
| Chronotropic index during 6-minute walk and acute respiratory events in COPDGene. | Macdonald DM et al. | โ | 2022 | โ |
| Clinical Characteristics of Non-Smoking Chronic Obstructive Pulmonary Disease Patients: Findings from the KOCOSS Cohort. | Choi JY et al. | โ | 2022 | โ |
| Clinically Significant and Comorbid Anxiety and Depression Symptoms Predict Severe Respiratory Exacerbations in Smokers: A <i>Post Hoc</i> Analysis of the COPDGene and SPIROMICS Cohorts. | Iyer AS et al. | โ | 2022 | โ |
| Cluster activation mapping with application to computed tomography scans of the lung. | Ryan SM et al. | โ | 2022 | โ |
| Clustering-based COPD subtypes have distinct longitudinal outcomes and multi-omics biomarkers. | Gregory A et al. | โ | 2022 | โ |
| CNN-based Deformable Registration Facilitates Fast and Accurate Air Trapping Measurements at Inspiratory and Expiratory CT. | Hasenstab KA et al. | โ | 2022 | โ |
| Collaborative Cohort of Cohorts for COVID-19 Research (C4R) Study: Study Design. | Oelsner EC et al. | โ | 2022 | โ |
| Computed Tomography Features of Lung Structure Have Utility for Differentiating Malignant and Benign Pulmonary Nodules. | Uthoff JM et al. | โ | 2022 | โ |
| Covariate adjustment of spirometric and smoking phenotypes: The potential of neural network models. | Voorhies K et al. | โ | 2022 | โ |
| Deep Learning Assessment of Emphysema Progression at CT Predicts Outcomes. | Grenier PA | โ | 2022 | โ |
| Depressive and anxiety symptoms in patients with COPD: A network analysis. | Yohannes AM et al. | โ | 2022 | โ |
| Development of a Blood-based Transcriptional Risk Score for Chronic Obstructive Pulmonary Disease. | Moll M et al. | โ | 2022 | โ |
| Effective Subject Representation based on Multi-omics Disease Networks using Graph Embedding. | Hussein S et al. | โ | 2022 | โ |
| Emphysema Progression at CT by Deep Learning Predicts Functional Impairment and Mortality: Results from the COPDGene Study. | Oh AS et al. | โ | 2022 | โ |
| GAWMerge expands GWAS sample size and diversity by combining array-based genotyping and whole-genome sequencing. | Mathur R et al. | โ | 2022 | โ |
| Gene-Based Association Tests Using New Polygenic Risk Scores and Incorporating Gene Expression Data. | Yan S et al. | โ | 2022 | โ |
| Hierarchical Amortized GAN for 3D High Resolution Medical Image Synthesis. | Sun L et al. | โ | 2022 | โ |
| Identifying Individual Medications Affecting Pulmonary Outcomes When Multiple Medications are Present. | Li Y et al. | โ | 2022 | โ |
| Improved Detection of Chronic Obstructive Pulmonary Disease at Chest CT Using the Mean Curvature of Isophotes. | Savadjiev P et al. | โ | 2022 | โ |
| Increased chest CT derived bone and muscle measures capture markers of improved morbidity and mortality in COPD. | Wilson AC et al. | โ | 2022 | โ |
| Interstitial lung abnormalities are associated with decreased mean telomere length. | Putman RK et al. | โ | 2022 | โ |
| Interstitial Lung Abnormalities, Emphysema, and Spirometry in Smokers. | Menon AA et al. | โ | 2022 | โ |
| Kidney and lung in pathology: mechanisms and clinical implications. | Satta E et al. | โ | 2022 | โ |
| Knowledge Distillation via Constrained Variational Inference. | Saeedi A et al. | โ | 2022 | โ |
| Longitudinal Association Between Muscle Loss and Mortality in Ever Smokers. | Mason SE et al. | โ | 2022 | โ |
| <i>C</i> <i>FTR</i> variants are associated with chronic bronchitis in smokers. | Saferali A et al. | โ | 2022 | โ |
| Lung tissue shows divergent gene expression between chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis. | Ghosh AJ et al. | โ | 2022 | โ |
| Machine Learning Prediction of Progression in Forced Expiratory Volume in 1 Second in the COPDGeneยฎ Study. | Boueiz A et al. | โ | 2022 | โ |
| Mechanism-aware imputation: a two-step approach in handling missing values in metabolomics. | Dekermanjian JP et al. | โ | 2022 | โ |
| Metabolome Features of COPD: A Scoping Review. | Godbole S et al. | โ | 2022 | โ |
| New Guidelines for Bronchodilator Responsiveness in COPD: A Test in Search of a Use. | Bhatt SP et al. | โ | 2022 | โ |
| Optimism is associated with respiratory symptoms and functional status in chronic obstructive pulmonary disease. | Koo HK et al. | โ | 2022 | โ |
| Origins of and lessons from quantitative functional X-ray computed tomography of the lung. | Hoffman EA | โ | 2022 | โ |
| Phenotypic Heterogeneity in Chronic Obstructive Pulmonary Disease. | Kaul M et al. | โ | 2022 | โ |
| Photon-counting CT versus conventional CT for COPD quantifications: intra-scanner optimization and inter-scanner assessments using virtual imaging trials. | Sotoudeh-Paima S et al. | โ | 2022 | โ |
| Physical Activity, Muscle Oxidative Capacity, and Coronary Artery Calcium in Smokers with and without COPD. | Tiller NB et al. | โ | 2022 | โ |
| Plasma sRAGE levels strongly associate with centrilobular emphysema assessed by HRCT scans. | Klont F et al. | โ | 2022 | โ |
| Predicting COPD Progression in Current and Former Smokers Using a Joint Model for Forced Expiratory Volume in 1 Second and Forced Expiratory Volume in 1 Second to Forced Vital Capacity Ratio. | Strand M et al. | โ | 2022 | โ |
| Quantitative imaging analysis detects subtle airway abnormalities in symptomatic military deployers. | Zell-Baran LM et al. | โ | 2022 | โ |
| Racial and Ethnic Minorities Have a Lower Prevalence of Airflow Obstruction than Non-Hispanic Whites. | Sood A et al. | โ | 2022 | โ |
| Review and classification of AI-enabled COVID-19 CT imaging models based on computer vision tasks. | Hassan H et al. | โ | 2022 | โ |
| Robust integrative biclustering for multi-view data. | Zhang W et al. | โ | 2022 | โ |
| Robust Measures of Image-Registration-Derived Lung Biomechanics in SPIROMICS. | Pan Y et al. | โ | 2022 | โ |
| Sex Differences in Airways at Chest CT: Results from the COPDGene Cohort. | Bhatt SP et al. | โ | 2022 | โ |
| Significant Spirometric Transitions and Preserved Ratio Impaired Spirometry Among Ever Smokers. | Wan ES et al. | โ | 2022 | โ |
| Single-material beam hardening correction via an analytical energy response model for diagnostic CT. | Haase V et al. | โ | 2022 | โ |
| sJIVE: Supervised Joint and Individual Variation Explained. | Palzer EF et al. | โ | 2022 | โ |
| Strain Analysis in Patients at High-Risk for COPD Using Four-Dimensional Dynamic-Ventilation CT. | Xu Y et al. | โ | 2022 | โ |
| The Severity of Functional Small Airway Disease in Military Personnel with Constrictive Bronchiolitis as Measured by Quantitative Computed Tomography. | Davis CW et al. | โ | 2022 | โ |
| Traction Bronchiectasis/Bronchiolectasis on CT Scans in Relationship to Clinical Outcomes and Mortality: The COPDGene Study. | Hata A et al. | โ | 2022 | โ |
| Unique and shared systemic biomarkers for emphysema in Alpha-1 Antitrypsin deficiency and chronic obstructive pulmonary disease. | Serban KA et al. | โ | 2022 | โ |
| Unsupervised Learning Identifies Computed Tomographic Measurements as Primary Drivers of Progression, Exacerbation, and Mortality in Chronic Obstructive Pulmonary Disease. | Yuan NF et al. | โ | 2022 | โ |
| Unsupervised segmentation and quantification of COVID-19 lesions on computed Tomography scans using CycleGAN. | Connell M et al. | โ | 2022 | โ |
| Whole genome sequencing identifies structural variants contributing to hematologic traits in the NHLBI TOPMed program. | Wheeler MM et al. | โ | 2022 | โ |
| A CT-Based Automated Algorithm for Airway Segmentation Using Freeze-and-Grow Propagation and Deep Learning. | Nadeem SA et al. | โ | 2021 | โ |
| A novel locus for exertional dyspnoea in childhood asthma. | Lee S et al. | โ | 2021 | โ |
| A Prospective Cohort Study to Assess Obstructive Respiratory Disease Phenotypes and Endotypes in Japan: The TRAIT Study Design. | Hizawa N et al. | โ | 2021 | โ |
| A review of deep learning in medical imaging: Imaging traits, technology trends, case studies with progress highlights, and future promises. | Zhou SK et al. | โ | 2021 | โ |
| Assessing bronchodilator response by changes in per cent predicted forced expiratory volume in one second. | Ioachimescu OC et al. | โ | 2021 | โ |
| Association between Inhaled Corticosteroids and Expiratory Central Airway Collapse in Smokers. | Hudali TH et al. | โ | 2021 | โ |
| Association of Systemic Inflammation with Depressive Symptoms in Individuals with COPD. | Strollo HC et al. | โ | 2021 | โ |
| A systematic analysis of protein-altering exonic variants in chronic obstructive pulmonary disease. | Moll M et al. | โ | 2021 | โ |
| A System for Phenotype Harmonization in the National Heart, Lung, and Blood Institute Trans-Omics for Precision Medicine (TOPMed) Program. | Stilp AM et al. | โ | 2021 | โ |
| Automated Assessment of COVID-19 Reporting and Data System and Chest CT Severity Scores in Patients Suspected of Having COVID-19 Using Artificial Intelligence. | Lessmann N et al. | โ | 2021 | โ |
| Automated CT Staging of Chronic Obstructive Pulmonary Disease Severity for Predicting Disease Progression and Mortality with a Deep Learning Convolutional Neural Network. | Hasenstab KA et al. | โ | 2021 | โ |
| Can contrastive learning avoid shortcut solutions? | Robinson J et al. | โ | 2021 | โ |
| Caution against examining the role of reverse causality in Mendelian Randomization. | Lutz SM et al. | โ | 2021 | โ |
| Chronic Bronchitis in COPD Patients Creates Worse Symptom Burden Regardless of the Presence of Bronchiectasis in the COPDGene Cohort. | Bohn O et al. | โ | 2021 | โ |
| Cigarette smoking-associated isoform switching and 3' UTR lengthening via alternative polyadenylation. | Xu Z et al. | โ | 2021 | โ |
| CNN-based lung CT registration with multiple anatomical constraints. | Hering A et al. | โ | 2021 | โ |
| Comparison of CT Lung Density Measurements between Standard Full-Dose and Reduced-Dose Protocols. | Hatt CR et al. | โ | 2021 | โ |
| Computed Tomography-based Airway Surface Area-to-Volume Ratio for Phenotyping Airway Remodeling in Chronic Obstructive Pulmonary Disease. | Bodduluri S et al. | โ | 2021 | โ |
| Context Matters: Graph-based Self-supervised Representation Learning for Medical Images. | Sun L et al. | โ | 2021 | โ |
| COPD Diagnosis: Time for Disruption. | Wouters EFM et al. | โ | 2021 | โ |
| CT image segmentation for inflamed and fibrotic lungs using a multi-resolution convolutional neural network. | Gerard SE et al. | โ | 2021 | โ |
| CT Pulmonary Vessels and MRI Ventilation in Chronic Obstructive Pulmonary Disease: Relationship with worsening FEV<sub>1</sub> in the TINCan cohort study. | Barker AL et al. | โ | 2021 | โ |
| Daily Activities: The Impact of COPD and Cognitive Dysfunction. | Brunette AM et al. | โ | 2021 | โ |
| Deterioration and Mortality Risk of COPD Patients Not Fitting into Standard GOLD Categories: Results of the COSYCONET Cohort. | Mayerhofer B et al. | โ | 2021 | โ |
| Determinants of Lung Fissure Completeness. | van der Molen MC et al. | โ | 2021 | โ |
| Development of the Advancing the Patient Experience in COPD Registry: A Modified Delphi Study. | Edwards CL et al. | โ | 2021 | โ |
| Discordant Quantitative and Visual CT Assessments in the Diagnosis of Emphysema. | Amaza IP et al. | โ | 2021 | โ |
| Distinguishing Smoking-Related Lung Disease Phenotypes Via Imaging and Molecular Features. | Billatos E et al. | โ | 2021 | โ |
| Emphysema Progression and Lung Function Decline Among Angiotensin Converting Enzyme Inhibitors and Angiotensin-Receptor Blockade Users in the COPDGene Cohort. | Tejwani V et al. | โ | 2021 | โ |
| Extracting Disease-Relevant Features with Adversarial Regularization. | Chen J et al. | โ | 2021 | โ |
| Feasibility of function-guided lung treatment planning with parametric response mapping. | Matrosic CK et al. | โ | 2021 | โ |
| Filtering Spatial Point Patterns Using Kernel Densities. | Vestal BE et al. | โ | 2021 | โ |
| Fleischner Society Visual Emphysema CT Patterns Help Predict Progression of Emphysema in Current and Former Smokers: Results from the COPDGene Study. | El Kaddouri B et al. | โ | 2021 | โ |
| FOOTPRINTS study protocol: rationale and methodology of a 3-year longitudinal observational study to phenotype patients with COPD. | Crapo J et al. | โ | 2021 | โ |
| Genetics plays a limited role in predicting chronic obstructive pulmonary disease treatment response and exacerbation. | Hosking L et al. | โ | 2021 | โ |
| Genetic variation in genes regulating skeletal muscle regeneration and tissue remodelling associated with weight loss in chronic obstructive pulmonary disease. | Lakshman Kumar P et al. | โ | 2021 | โ |
| Genome-Wide Gene-by-Smoking Interaction Study of Chronic Obstructive Pulmonary Disease. | Kim W et al. | โ | 2021 | โ |
| GenoPheno: cataloging large-scale phenotypic and next-generation sequencing data within human datasets. | Gutiรฉrrez-Sacristรกn A et al. | โ | 2021 | โ |
| Haemoglobin as a biomarker for clinical outcomes in chronic obstructive pulmonary disease. | Balasubramanian A et al. | โ | 2021 | โ |
| Harmonization of in-plane resolution in CT using multiple reconstructions from single acquisitions. | Vegas-Sรกnchez-Ferrero G et al. | โ | 2021 | โ |
| Hedgehog interacting protein-expressing lung fibroblasts suppress lymphocytic inflammation in mice. | Yun JH et al. | โ | 2021 | โ |
| Identification of Metabolism-Associated Molecular Subtypes of Chronic Obstructive Pulmonary Disease. | Hu Y et al. | โ | 2021 | โ |
| Identification of putative causal loci in whole-genome sequencing data via knockoff statistics. | He Z et al. | โ | 2021 | โ |
| Identifying a Heart Rate Recovery Criterion After a 6-Minute Walk Test in COPD. | Zhao D et al. | โ | 2021 | โ |
| Impact of a Medical Diagnosis on Decision to Stop Smoking and Successful Smoking Cessation. | Lindsay HG et al. | โ | 2021 | โ |
| Impact of Comorbidity Prevalence and Cardiovascular Disease Status on the Efficacy and Safety of Nebulized Glycopyrrolate in Patients with COPD. | Putcha N et al. | โ | 2021 | โ |
| Improved detection of air trapping on expiratory computed tomography using deep learning. | Ram S et al. | โ | 2021 | โ |
| Improved prediction of smoking status via isoform-aware RNA-seq deep learning models. | Wang Z et al. | โ | 2021 | โ |
| Improving clinical disease subtyping and future events prediction through a chest CT-based deep learning approach. | Singla S et al. | โ | 2021 | โ |
| Incorporating External Information in Tissue Subtyping: A Topic Modeling Approach. | Saeedi A et al. | โ | 2021 | โ |
| Increased mortality associated with frequent exacerbations in COPD patients with mild-to-moderate lung function impairment, and smokers with normal spirometry. | Fortis S et al. | โ | 2021 | โ |
| Inhaled Medication Use in Smokers With Normal Spirometry. | R Arnold N et al. | โ | 2021 | โ |
| Investigation of the Clinical, Radiological and Biological Factors Associated with Disease Progression, Phenotypes and Endotypes of COPD in China (COMPASS): study design, protocol and rationale. | Liang Z et al. | โ | 2021 | โ |
| locStra: Fast analysis of regional/global stratification in whole-genome sequencingย studies. | Hahn G et al. | โ | 2021 | โ |
| <i>ZBTB33</i> is mutated in clonal hematopoiesis and myelodysplastic syndromes and impacts RNA splicing. | Beauchamp EM et al. | โ | 2021 | โ |
| Lung Fissural Integrity: It's Written in the Genes. | Garner JL et al. | โ | 2021 | โ |
| Metabolomic Profiling Reveals Sex Specific Associations with Chronic Obstructive Pulmonary Disease and Emphysema. | Gillenwater LA et al. | โ | 2021 | โ |
| Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment. | Polverino F et al. | โ | 2021 | โ |
| Metformin use and respiratory outcomes in asthma-COPD overlap. | Wu TD et al. | โ | 2021 | โ |
| Mucus plugging on computed tomography and chronic bronchitis in chronic obstructive pulmonary disease. | Kim V et al. | โ | 2021 | โ |
| Multi-omics subtyping pipeline for chronic obstructive pulmonary disease. | Gillenwater LA et al. | โ | 2021 | โ |
| On a New Approach to Assess Bronchodilator Responsiveness. | Ioachimescu OC | โ | 2021 | โ |
| Paired CT Measures of Emphysema and Small Airways Disease and Lung Function and Exercise Capacity in Smokers with Radiographic Bronchiectasis. | Martinez CH et al. | โ | 2021 | โ |
| PaIRKAT: A pathway integrated regression-based kernel association test with applications to metabolomics and COPD phenotypes. | Carpenter CM et al. | โ | 2021 | โ |
| Peripheral blood microbial signatures in current and former smokers. | Morrow JD et al. | โ | 2021 | โ |
| Progression of Emphysema and Small Airways Disease in Cigarette Smokers. | Pompe E et al. | โ | 2021 | โ |
| Protein Biomarkers for COPD Outcomes. | Serban KA et al. | โ | 2021 | โ |
| Protocol Summary of the COPD Assessment in Primary Care To Identify Undiagnosed Respiratory Disease and Exacerbation Risk (CAPTURE) Validation in Primary Care Study. | Yawn BP et al. | โ | 2021 | โ |
| Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients. | Ezponda A et al. | โ | 2021 | โ |
| Psoas Muscle Density Evaluated by Chest CT and Long-Term Mortality in COPD Patients. | Ezponda A et al. | โ | 2021 | โ |
| Pulmonary Arterial Pruning and Longitudinal Change in Percent Emphysema and Lung Function: The Genetic Epidemiology of COPD Study. | Pistenmaa CL et al. | โ | 2021 | โ |
| Pulmonary Artery Enlargement Is Associated with Exacerbations and Mortality in Ever-Smokers with Preserved Ratio Impaired Spirometry. | Wade RC et al. | โ | 2021 | โ |
| Pulmonary Hypertension in Association with Lung Disease: Quantitative CT and Artificial Intelligence to the Rescue? State-of-the-Art Review. | Dwivedi K et al. | โ | 2021 | โ |
| Quantitative Analysis of Adipose Depots by Using Chest CT and Associations with All-Cause Mortality in Chronic Obstructive Pulmonary Disease: Longitudinal Analysis from MESArthritis Ancillary Study. | Pishgar F et al. | โ | 2021 | โ |
| Quantitative CT-Based Methods for Bone Microstructural Measures and Their Relationships With Vertebral Fractures in a Pilot Study on Smokers. | Zhang X et al. | โ | 2021 | โ |
| Quantitative CT metrics are associated with longitudinal lung function decline and future asthma exacerbations: Results from SARP-3. | Krings JG et al. | โ | 2021 | โ |
| Racial Differences in Prevalence and Clinical Characteristics of Asthma-Chronic Obstructive Pulmonary Disease Overlap. | Jo YS et al. | โ | 2021 | โ |
| Rare deleterious germline variants and risk of lung cancer. | Liu Y et al. | โ | 2021 | โ |
| Rationale and design of the Early Chronic Obstructive Pulmonary Disease (ECOPD) study in Guangdong, China: a prospective observational cohort study. | Wu F et al. | โ | 2021 | โ |
| Relationship between Emphysema Progression at CT and Mortality in Ever-Smokers: Results from the COPDGene and ECLIPSE Cohorts. | Ash SY et al. | โ | 2021 | โ |
| Reproducibility of mass spectrometry based metabolomics data. | Ghosh T et al. | โ | 2021 | โ |
| Respiratory exacerbations are associated with muscle loss in current and former smokers. | Mason SE et al. | โ | 2021 | โ |
| Secondary polycythemia in chronic obstructive pulmonary disease: prevalence and risk factors. | Zhang J et al. | โ | 2021 | โ |
| Serum Acylglycerols Inversely Associate with Muscle Oxidative Capacity in Severe COPD. | Li R et al. | โ | 2021 | โ |
| Small Airway Disease and Emphysema Are Associated with Future Exacerbations in Smokers with CT-derived Bronchiectasis and COPD: Results from the COPDGene Cohort. | Maselli DJ et al. | โ | 2021 | โ |
| Soluble receptor for advanced glycation end products (sRAGE) as a biomarker of COPD. | Pratte KA et al. | โ | 2021 | โ |
| Structural airway imaging metrics are differentially associated with persistent chronic bronchitis. | Bhatt SP et al. | โ | 2021 | โ |
| Structural and functional changes in COPD: What we have learned from imaging. | Benlala I et al. | โ | 2021 | โ |
| The Association Between Lung Hyperinflation and Coronary Artery Disease in Smokers. | Chandra D et al. | โ | 2021 | โ |
| The different phenotypes of COPD. | Yousuf A et al. | โ | 2021 | โ |
| The impacts of parity on spirometric parameters: a systematic review. | Triki L et al. | โ | 2021 | โ |
| Transcriptomic Signature of Asthma-Chronic Obstructive Pulmonary Disease Overlap in Whole Blood. | Saferali A et al. | โ | 2021 | โ |
| Ultra-low-dose CT combined with noise reduction techniques for quantification of emphysema in COPD patients: An intra-individual comparison study with standard-dose CT. | Wisselink HJ et al. | โ | 2021 | โ |
| Understanding racial differences of COPD patients with an ecological model: two large cohort studies in the US and Korea. | Park HY et al. | โ | 2021 | โ |
| Unpaired data empowers association tests. | Gong M et al. | โ | 2021 | โ |
| Using Blood Eosinophil Count as a Biomarker to Guide Corticosteroid Treatment for Chronic Obstructive Pulmonary Disease. | Sivapalan P et al. | โ | 2021 | โ |
| Whole-Exome Sequencing Implicates the <i>USP34</i> rs777591A > G Intron Variant in Chronic Obstructive Pulmonary Disease in a Kashi Cohort. | Xu J et al. | โ | 2021 | โ |
| Whole-genome sequencing in diverse subjects identifies genetic correlates of leukocyte traits: The NHLBI TOPMed program. | Mikhaylova AV et al. | โ | 2021 | โ |
| A Between Ethnicities Comparison of Chronic Obstructive Pulmonary Disease Genetic Risk. | Gim J et al. | โ | 2020 | โ |
| Adult Life-Course Trajectories of Lung Function and the Development of Emphysema: The CARDIA Lung Study. | Washko GR et al. | โ | 2020 | โ |
| Advances in Chronic Obstructive Pulmonary Disease Imaging. | Dolliver WR et al. | โ | 2020 | โ |
| A flexible and nearly optimal sequential testing approach to randomized testing: QUICK-STOP. | Hecker J et al. | โ | 2020 | โ |
| A general framework for integrative analysis of incomplete multiomics data. | Lin DY et al. | โ | 2020 | โ |
| Anatomical Labeling of Human Airway Branches using a Novel Two-Step Machine Learning and Hierarchical Features. | Nadeem SA et al. | โ | 2020 | โ |
| An open-source framework for pulmonary fissure completeness assessment. | Ross JC et al. | โ | 2020 | โ |
| A quantitative analysis of biomechanical lung model consistency using 5DCT datasets. | Stiehl B et al. | โ | 2020 | โ |
| A Risk Prediction Model for Mortality Among Smokers in the COPDGeneยฎ Study. | Strand M et al. | โ | 2020 | โ |
| Artificial Intelligence in COPD: New Venues to Study a Complex Disease. | Estรฉpar RSJ | โ | 2020 | โ |
| Association between the number and size of intrapulmonary lymph nodes and chronic obstructive pulmonary disease severity. | Schreuder A et al. | โ | 2020 | โ |
| Bayesian inference of networks across multiple sample groups and data types. | Shaddox E et al. | โ | 2020 | โ |
| Biomarker Localization From Deep Learning Regression Networks. | Cano-Espinosa C et al. | โ | 2020 | โ |
| Carotid Artery Stiffness is Associated With Cognitive Performance in Former Smokers With and Without Chronic Obstructive Pulmonary Disease. | Hoth KF et al. | โ | 2020 | โ |
| "Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art." | Corlateanu A et al. | โ | 2020 | โ |
| Chronic obstructive pulmonary disease and related phenotypes: polygenic risk scores in population-based and case-control cohorts. | Moll M et al. | โ | 2020 | โ |
| Classification of Exacerbation Frequency in the COPDGene Cohort Using Deep Learning With Deep Belief Networks. | Ying J et al. | โ | 2020 | โ |
| Classification of Interstitial Lung Abnormality Patterns with an Ensemble of Deep Convolutional Neural Networks. | Bermejo-Pelรกez D et al. | โ | 2020 | โ |
| Clinical Phenotypes of Atopy and Asthma in COPD: A Meta-analysis of SPIROMICS and COPDGene. | Putcha N et al. | โ | 2020 | โ |
| Comparison of Proteomic Assessment Methods in Multiple Cohort Studies. | Raffield LM et al. | โ | 2020 | โ |
| Deep Learning Enables Automatic Classification of Emphysema Pattern at CT. | Humphries SM et al. | โ | 2020 | โ |
| Deep neural network analyses of spirometry for structural phenotyping of chronic obstructive pulmonary disease. | Bodduluri S et al. | โ | 2020 | โ |
| Diffuse Idiopathic Skeletal Hyperostosis in Smokers and Restrictive Spirometry Pattern: An Analysis of the COPDGene Cohort. | Oudkerk SF et al. | โ | 2020 | โ |
| Disease Progression Modeling in Chronic Obstructive Pulmonary Disease. | Young AL et al. | โ | 2020 | โ |
| DNA Methylation Is Predictive of Mortality in Current and Former Smokers. | Morrow JD et al. | โ | 2020 | โ |
| Early imaging biomarkers of lung cancer, COPD and coronary artery disease in the general population: rationale and design of the ImaLife (Imaging in Lifelines) Study. | Xia C et al. | โ | 2020 | โ |
| Evaluation of Changes in Control Status in COPD: An Opportunity for Early Intervention. | Soler X | โ | 2020 | โ |
| Factors influencing decline in quality of life in smokers without airflow obstruction: The COPDGene study. | Parekh TM et al. | โ | 2020 | โ |
| Five-year Progression of Emphysema and Air Trapping at CT in Smokers with and Those without Chronic Obstructive Pulmonary Disease: Results from the COPDGene Study. | Pompe E et al. | โ | 2020 | โ |
| FSTL-1 Attenuation Causes Spontaneous Smoke-Resistant Pulmonary Emphysema. | Henkel M et al. | โ | 2020 | โ |
| Generative-based airway and vessel morphology quantification on chest CT images. | Nardelli P et al. | โ | 2020 | โ |
| Heme metabolism genes Downregulated in COPD Cachexia. | Wilson AC et al. | โ | 2020 | โ |
| Identifying Protein-metabolite Networks Associated with COPD Phenotypes. | Mastej E et al. | โ | 2020 | โ |
| Immunoglobulin E as a Biomarker for the Overlap of Atopic Asthma and Chronic Obstructive Pulmonary Disease. | Hersh CP et al. | โ | 2020 | โ |
| Impact of gastroesophageal reflux on longitudinal lung function and quantitative computed tomography in the COPDGene cohort. | Baldomero AK et al. | โ | 2020 | โ |
| Inter- and intra-software reproducibility of computed tomography lung density measurements. | Kirby M et al. | โ | 2020 | โ |
| Joint analysis of multiple phenotypes using a clustering linear combination method based on hierarchical clustering. | Li X et al. | โ | 2020 | โ |
| KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea. | Lee H et al. | โ | 2020 | โ |
| Learning to Quantify Emphysema Extent: What Labels Do We Need? | Orting SN et al. | โ | 2020 | โ |
| LOCALLY ADAPTIVE HALF-MAX METHODS FOR AIRWAY LUMEN-AREA AND WALL-THICKNESS AND THEIR REPEAT CT SCAN REPRODUCIBILITY. | Nadeem SA et al. | โ | 2020 | โ |
| Low FVC/TLC in Preserved Ratio Impaired Spirometry (PRISm) is associated with features of and progression to obstructive lung disease. | Fortis S et al. | โ | 2020 | โ |
| Luminal Plugging on Chest CT Scan: Association With Lung Function, Quality of Life, and COPD Clinical Phenotypes. | Okajima Y et al. | โ | 2020 | โ |
| Lung function decline in former smokers and low-intensity current smokers: a secondary data analysis of the NHLBI Pooled Cohorts Study. | Oelsner EC et al. | โ | 2020 | โ |
| Lung-Specific Risk Factors Associated With Incident Hip Fracture in Current and Former Smokers. | Bon J et al. | โ | 2020 | โ |
| Machine Learning Characterization of COPD Subtypes: Insights From the COPDGene Study. | Castaldi PJ et al. | โ | 2020 | โ |
| Mixed-model admixture mapping identifies smoking-dependent loci of lung function in African Americans. | Ziyatdinov A et al. | โ | 2020 | โ |
| Multicenter evaluation of parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. | Cheng GS et al. | โ | 2020 | โ |
| Multi-resolution convolutional neural networks for fully automated segmentation of acutely injured lungs in multiple species. | Gerard SE et al. | โ | 2020 | โ |
| Observational studies assessing the pharmacological treatment of obstructive lung disease: strengths, challenges and considerations for study design. | Vestbo J et al. | โ | 2020 | โ |
| Ordered multinomial regression for genetic association analysis of ordinal phenotypes at Biobank scale. | German CA et al. | โ | 2020 | โ |
| Particle transport and deposition correlation with near-wall flow characteristic under inspiratory airflow in lung airways. | Farghadan A et al. | โ | 2020 | โ |
| Phenotypic characterisation of early COPD: a prospective case-control study. | Cosรญo BG et al. | โ | 2020 | โ |
| Plasma Cathelicidin is Independently Associated with Reduced Lung Function in COPD: Analysis of the Subpopulations and Intermediate Outcome Measures in COPD Study Cohort. | Burkes RM et al. | โ | 2020 | โ |
| Plasma Metabolomic Signatures of Chronic Obstructive Pulmonary Disease and the Impact of Genetic Variants on Phenotype-Driven Modules. | Gillenwater LA et al. | โ | 2020 | โ |
| Prediction of Obstructive Lung Disease from Chest Radiographs via Deep Learning Trained on Pulmonary Function Data. | Schroeder JD et al. | โ | 2020 | โ |
| Prediction of radiation pneumonitis using dose-volume histogram parameters with high attenuation in two types of cancer: A retrospective study. | Uchida Y et al. | โ | 2020 | โ |
| Predictive Modeling for Metabolomics Data. | Ghosh T et al. | โ | 2020 | โ |
| Pulmonary artery enlargement and mortality risk in moderate to severe COPD: results from COPDGene. | LaFon DC et al. | โ | 2020 | โ |
| Pulmonary Imaging Phenotypes of Chronic Obstructive Pulmonary Disease Using Multiparametric Response Maps. | MacNeil JL et al. | โ | 2020 | โ |
| Pulmonary Low Attenuation Areas on CT in ANCA-associated Vasculitis: A quantitative and semi-quantitative analysis correlated with pulmonary function testing for obstructive airway disease. | Cox CW et al. | โ | 2020 | โ |
| Quantitative CT detects progression in COPD patients with severe emphysema in a 3-month interval. | Konietzke P et al. | โ | 2020 | โ |
| Relational Modeling for Robust and Efficient Pulmonary Lobe Segmentation in CT Scans. | Xie W et al. | โ | 2020 | โ |
| Relative contributions of family history and a polygenic risk score on COPD and related outcomes: COPDGene and ECLIPSE studies. | Moll M et al. | โ | 2020 | โ |
| Smaller Left Ventricle Size at Noncontrast CT Is Associated with Lower Mortality in COPDGene Participants. | Washko GR et al. | โ | 2020 | โ |
| Somatotypes trajectories during adulthood and their association with COPD phenotypes. | Divo MJ et al. | โ | 2020 | โ |
| Subtyping COPD by Using Visual and Quantitative CT Imaging Features. | Park J et al. | โ | 2020 | โ |
| Template Creation for High-Resolution Computed Tomography Scans of the Lung in R Software. | Ryan SM et al. | โ | 2020 | โ |
| Testing gene-environment interactions for rare and/or common variants in sequencing association studies. | Zhao Z et al. | โ | 2020 | โ |
| The Association of Multiparity with Lung Function and Chronic Obstructive Pulmonary Disease-Related Phenotypes. | Moll M et al. | โ | 2020 | โ |
| The Technome - A Predictive Internal Calibration Approach for Quantitative Imaging Biomarker Research. | Mรผhlberg A et al. | โ | 2020 | โ |
| Translation of adapting quantitative CT data from research to local clinical practice: validation evaluation of fully automated procedures to provide lung volumes and percent emphysema. | Leung KM et al. | โ | 2020 | โ |
| Using Quantitative Computed Tomographic Imaging to Understand Chronic Obstructive Pulmonary Disease and Fibrotic Interstitial Lung Disease: State of the Art and Future Directions. | Castillo-Saldana D et al. | โ | 2020 | โ |
| Validation of a method to assess emphysema severity by spirometry in the COPDGene study. | Occhipinti M et al. | โ | 2020 | โ |
| Visual Emphysema at Chest CT in GOLD Stage 0 Cigarette Smokers Predicts Disease Progression: Results from the COPDGene Study. | Oh AS et al. | โ | 2020 | โ |
| Vitamin D deficiency is associated with respiratory symptoms and airway wall thickening in smokers with and without COPD: a prospective cohort study. | Ghosh AJ et al. | โ | 2020 | โ |
| When Harry Met Sally, or When Machine Learning Met Chronic Obstructive Pulmonary Disease. | Agusti A et al. | โ | 2020 | โ |
| A clustering linear combination approach to jointly analyze multiple phenotypes for GWAS. | Sha Q et al. | โ | 2019 | โ |
| Acquired Cystic Fibrosis Transmembrane Conductance Regulator Dysfunction and Radiographic Bronchiectasis in Current and Former Smokers: A Cross-Sectional Study. | Teerapuncharoen K et al. | โ | 2019 | โ |
| A functional macrophage migration inhibitory factor promoter polymorphism is associated with reduced diffusing capacity. | Zhang C et al. | โ | 2019 | โ |
| A gene based approach to test genetic association based on an optimally weighted combination of multiple traits. | Zhang J et al. | โ | 2019 | โ |
| A genome-wide association study implicates <i>NR2F2</i> in lymphangioleiomyomatosis pathogenesis. | Kim W et al. | โ | 2019 | โ |
| A graph-cut approach for pulmonary artery-vein segmentation in noncontrast CT images. | Jimenez-Carretero D et al. | โ | 2019 | โ |
| Airway morphology and inspiratory flow features in the early stages of Chronic Obstructive Pulmonary Disease. | Van de Moortele T et al. | โ | 2019 | โ |
| Airway wall thickening on CT: Relation to smoking status and severity of COPD. | Charbonnier JP et al. | โ | 2019 | โ |
| Analysis of genetically driven alternative splicing identifies FBXO38 as a novel COPD susceptibility gene. | Saferali A et al. | โ | 2019 | โ |
| A New Bronchodilator Response Grading Strategy Identifies Distinct Patient Populations. | Hansen JE et al. | โ | 2019 | โ |
| Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study. | Washko GR et al. | โ | 2019 | โ |
| Assessing pleiotropy and mediation in genetic loci associated with chronic obstructive pulmonary disease. | Parker MM et al. | โ | 2019 | โ |
| Assessing pulmonary hypertension in COPD. Is there a role for computed tomography? | Coste F et al. | โ | 2019 | โ |
| Association of Obesity with Quantitative Chest CT Measured Airway Wall Thickness in WTC Workers with Lower Airway Disease. | de la Hoz RE et al. | โ | 2019 | โ |
| Biomedical Image Processing with Containers and Deep Learning: An Automated Analysis Pipeline: Data architecture, artificial intelligence, automated processing, containerization, and clusters orchestration ease the transition from data acquisition to insights in medium-to-large datasets. | Gonzรกlez G et al. | โ | 2019 | โ |
| CASMAP: detection of statistically significant combinations of SNPs in association mapping. | Llinares-Lรณpez F et al. | โ | 2019 | โ |
| Clinical Epidemiology of COPD: Insights From 10 Years of the COPDGene Study. | Maselli DJ et al. | โ | 2019 | โ |
| Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease. | Fortis S et al. | โ | 2019 | โ |
| Common and Rare Variants Genetic Association Analysis of Cigarettes per Day Among Ever-Smokers in Chronic Obstructive Pulmonary Disease Cases and Controls. | Lutz SM et al. | โ | 2019 | โ |
| Computational modeling of lung deposition of inhaled particles in chronic obstructive pulmonary disease (COPD) patients: identification of gaps in knowledge and data. | Ganguly K et al. | โ | 2019 | โ |
| COPDGene<sup>ยฎ</sup> 2019: Redefining the Diagnosis of Chronic Obstructive Pulmonary Disease. | Lowe KE et al. | โ | 2019 | โ |
| Criteria for Early-Phase Diffuse Idiopathic Skeletal Hyperostosis: Development and Validation. | Kuperus JS et al. | โ | 2019 | โ |
| Current Controversies in Chronic Obstructive Pulmonary Disease. A Report from the Global Initiative for Chronic Obstructive Lung Disease Scientific Committee. | Criner GJ et al. | โ | 2019 | โ |
| Defining severe obstructive lung disease in the biologic era: an endotype-based approach. | Martin RJ et al. | โ | 2019 | โ |
| Diffusing Capacity of Carbon Monoxide inย Assessment of COPD. | Balasubramanian A et al. | โ | 2019 | โ |
| Direct Automatic Coronary Calcium Scoring in Cardiac and Chest CT. | de Vos BD et al. | โ | 2019 | โ |
| DSP variants may be associated with longitudinal change in quantitative emphysema. | Kim W et al. | โ | 2019 | โ |
| Effect of population stratification on SNP-by-environment interaction. | An J et al. | โ | 2019 | โ |
| Evaluation of exacerbations and blood eosinophils in UK and US COPD populations. | Vogelmeier CF et al. | โ | 2019 | โ |
| Evolving Concepts in Chronic Obstructive Pulmonary Disease Blood-Based Biomarkers. | Cazzola M et al. | โ | 2019 | โ |
| Feasibility of deriving a novel imaging biomarker based on patient-specific lung elasticity for characterizing the degree of COPD in lung SBRT patients. | Hasse K et al. | โ | 2019 | โ |
| Fifty Years of Progress in the Epidemiology of Chronic Obstructive Pulmonary Disease: A Review of National Heart, Lung, and Blood Institute-Sponsored Studies. | Mannino DM | โ | 2019 | โ |
| FissureNet: A Deep Learning Approach For Pulmonary Fissure Detection in CT Images. | Gerard SE et al. | โ | 2019 | โ |
| Gene fingerprint model for literature based detection of the associations among complex diseases: a case study of COPD. | Chen G et al. | โ | 2019 | โ |
| Genetic landscape of chronic obstructive pulmonary disease identifies heterogeneous cell-type and phenotype associations. | Sakornsakolpat P et al. | โ | 2019 | โ |
| GWAS and systems biology analysis of depressive symptoms among smokers from the COPDGene cohort. | Heinzman JT et al. | โ | 2019 | โ |
| Identification of an emphysema-associated genetic variant near <i>TGFB2</i> with regulatory effects in lung fibroblasts. | Parker MM et al. | โ | 2019 | โ |
| Identification of Nonaggressive Pulmonary Nodules Using an Optimized Scoring System. | Stephens MJ et al. | โ | 2019 | โ |
| Imaging Advances in Chronic Obstructive Pulmonary Disease. Insights from the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene) Study. | Bhatt SP et al. | โ | 2019 | โ |
| Impact of fatty acid binding protein 5-deficiency on COPD exacerbations and cigarette smoke-induced inflammatory response to bacterial infection. | Rao DM et al. | โ | 2019 | โ |
| Impaired non-homologous end joining in human primary alveolar type II cells in emphysema. | Kosmider B et al. | โ | 2019 | โ |
| <i>MUC5B</i> variant is associated with visually and quantitatively detected preclinical pulmonary fibrosis. | Mathai SK et al. | โ | 2019 | โ |
| Increased Airway Wall Thickness in Interstitial Lung Abnormalities and Idiopathic Pulmonary Fibrosis. | Miller ER et al. | โ | 2019 | โ |
| Influence of Inspiratory/Expiratory CT Registration on Quantitative Air Trapping. | Weinheimer O et al. | โ | 2019 | โ |
| LOCALIZING IMAGE-BASED BIOMARKER REGRESSION WITHOUT TRAINING MASKS: A NEW APPROACH TO BIOMARKER DISCOVERY. | Cano-Espinosa C et al. | โ | 2019 | โ |
| Longitudinal airway remodeling in active and past smokers in a lung cancer screening population. | Jobst BJ et al. | โ | 2019 | โ |
| Long Noncoding Transcriptome in Chronic Obstructive Pulmonary Disease. | Devadoss D et al. | โ | 2019 | โ |
| Machine learning approach for distinguishing malignant and benign lung nodules utilizing standardized perinodular parenchymal features from CT. | Uthoff J et al. | โ | 2019 | โ |
| metaFARVAT: An Efficient Tool for Meta-Analysis of Family-Based, Case-Control, and Population-Based Rare Variant Association Studies. | Wang L et al. | โ | 2019 | โ |
| MM ALGORITHMS FOR VARIANCE COMPONENT ESTIMATION AND SELECTION IN LOGISTIC LINEAR MIXED MODEL. | Hu L et al. | โ | 2019 | โ |
| MM Algorithms For Variance Components Models. | Zhou H et al. | โ | 2019 | โ |
| Mortality and Exacerbations by Global Initiative for Chronic Obstructive Lung Disease Groups ABCD: 2011 Versus 2017 in the COPDGeneยฎ Cohort. | Criner RN et al. | โ | 2019 | โ |
| Multi-target natural products as alternatives against oxidative stress in Chronic Obstructive Pulmonary Disease (COPD). | Gonรงalves PB et al. | โ | 2019 | โ |
| Noninvasive Imaging Biomarker Identifies Small Airway Damage in Severe Chronic Obstructive Pulmonary Disease. | Vasilescu DM et al. | โ | 2019 | โ |
| Objectively Measured Chronic Lung Injuryย on Chest CT. | Harmouche R et al. | โ | 2019 | โ |
| Omics and the Search for Blood Biomarkers in Chronic Obstructive Pulmonary Disease. Insights from COPDGene. | Regan EA et al. | โ | 2019 | โ |
| Pathogenesis of chronic obstructive pulmonary disease (COPD) induced by cigarette smoke. | Hikichi M et al. | โ | 2019 | โ |
| Peripheral Blood Eosinophil as a Biomarker in Outcomes of Acute Exacerbation of Chronic Obstructive Pulmonary Disease. | Wu HX et al. | โ | 2019 | โ |
| Pharmacogenomics of chronic obstructive pulmonary disease. | Hersh CP | โ | 2019 | โ |
| Physiologic Insights from the COPD Genetic Epidemiology Study. | Stringer WW et al. | โ | 2019 | โ |
| Post-imaging pulmonary nodule mathematical prediction models: are they clinically relevant? | Uthoff J et al. | โ | 2019 | โ |
| Pre-analytic Considerations for Mass Spectrometry-Based Untargeted Metabolomics Data. | Reinhold D et al. | โ | 2019 | โ |
| Pulmonary Subtypes Exhibit Differential Global Initiative for Chronic Obstructive Lung Disease Spirometry Stage Progression: The COPDGeneยฎ Study. | Young KA et al. | โ | 2019 | โ |
| Quantitative CT analysis in patients with pulmonary emphysema: is lung function influenced by concomitant unspecific pulmonary fibrosis? | Feldhaus FW et al. | โ | 2019 | โ |
| Quantitative CT of Interstitial Lung Disease. | Newell JD et al. | โ | 2019 | โ |
| Radiomic measures from chest high-resolution computed tomography associated with lung function in sarcoidosis. | Ryan SM et al. | โ | 2019 | โ |
| Real-world use of rescue inhaler sensors, electronic symptom questionnaires and physical activity monitors in COPD. | Bowler R et al. | โ | 2019 | โ |
| Redefining DISH: A Catalyst for Advancement of Research? | Block JJ | โ | 2019 | โ |
| Reduced Attention in Former Smokers with and without COPD. | Croghan A et al. | โ | 2019 | โ |
| Relationship between current smoking, visual CT findings and emphysema index in cigarette smokers. | Jou SS et al. | โ | 2019 | โ |
| Relationship of spirometric, body plethysmographic, and diffusing capacity parameters to emphysema scores derived from CT scans. | Kahnert K et al. | โ | 2019 | โ |
| Reprint of: Voxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in Smokers. | Labaki WW et al. | โ | 2019 | โ |
| RNA-sequencing across three matched tissues reveals shared and tissue-specific gene expression and pathway signatures of COPD. | Morrow JD et al. | โ | 2019 | โ |
| S100A8 Protects Human Primary Alveolar Type II Cells against Injury and Emphysema. | Lin CR et al. | โ | 2019 | โ |
| Spirometric assessment of emphysema presence and severity as measured by quantitative CT and CT-based radiomics in COPD. | Occhipinti M et al. | โ | 2019 | โ |
| Subjects with diffuse idiopathic skeletal hyperostosis have an increased burden of coronary artery disease: An evaluation in the COPDGene cohort. | Oudkerk SF et al. | โ | 2019 | โ |
| Subtypes of COPD Have Unique Distributions and Differential Risk of Mortality. | Young KA et al. | โ | 2019 | โ |
| Symptoms of anxiety and depression and use of anxiolytic-hypnotics and antidepressants in current and former smokers with and without COPD - A cross sectional analysis of the COPDGene cohort. | Iyer AS et al. | โ | 2019 | โ |
| Test Gene-Environment Interactions for Multiple Traits in Sequencing Association Studies. | Zhang J et al. | โ | 2019 | โ |
| The Peak Index: Exploring the Heterogeneity of Airflow Obstruction, Using Simple Spirometry. | Ostridge K | โ | 2019 | โ |
| The Peak Index: Spirometry Metric for Airflow Obstruction Severity and Heterogeneity. | Bhatt SP et al. | โ | 2019 | โ |
| The Pressing Need to Redefine "COPD". | Barnes PJ et al. | โ | 2019 | โ |
| The Severity of Oxidative Stress in Comorbid Chronic Obstructive Pulmonary Disease (COPD) and Hypertension: Does it Depend On ACE and AGT Gene Polymorphisms? | Marushchak M et al. | โ | 2019 | โ |
| The St. George's Respiratory Questionnaire Definition of Chronic Bronchitis May Be aย Better Predictor of COPD Exacerbations Compared With the Classic Definition. | Kim V et al. | โ | 2019 | โ |
| Unsupervised discovery of phenotype-specific multi-omics networks. | Shi WJ et al. | โ | 2019 | โ |
| Using a spatial point process framework to characterize lung computed tomography scans. | Vestal BE et al. | โ | 2019 | โ |
| Validated imaging biomarkers as decision-making tools in clinical trials and routine practice: current status and recommendations from the EIBALL* subcommittee of the European Society of Radiology (ESR). | deSouza NM et al. | โ | 2019 | โ |
| Voxel-Wise Longitudinal Parametric Response Mapping Analysis of Chest Computed Tomography in Smokers. | Labaki WW et al. | โ | 2019 | โ |
| A Bayesian Approach for Learning Gene Networks Underlying Disease Severity in COPD. | Shaddox E et al. | โ | 2018 | โ |
| Accurate and adaptive imputation of summary statistics in mixed-ethnicity cohorts. | Togninalli M et al. | โ | 2018 | โ |
| A hierarchical clustering method for dimension reduction in joint analysis of multiple phenotypes. | Liang X et al. | โ | 2018 | โ |
| Airway fractal dimension predicts respiratory morbidity and mortality in COPD. | Bodduluri S et al. | โ | 2018 | โ |
| A novel method to test associations between a weighted combination of phenotypes and genetic variants. | Zhu H et al. | โ | 2018 | โ |
| A prototypic small molecule database for bronchoalveolar lavage-based metabolomics. | Walmsley S et al. | โ | 2018 | โ |
| Artificial Intelligence and Chest Imaging. Will Deep Learning Make Us Smarter? | Labaki WW et al. | โ | 2018 | โ |
| Association between Emphysema and Chronic Obstructive Pulmonary Disease Outcomes in the COPDGene and SPIROMICS Cohorts: A Post Hoc Analysis of Two Clinical Trials. | Han MK et al. | โ | 2018 | โ |
| Association between multidrug resistance-1 C3435T gene polymorphism and right ventricular dysfunction in patients with chronic obstructive pulmonary disease: cross-sectional study. | Yรผcel O et al. | โ | 2018 | โ |
| Association of low income with pulmonary disease progression in smokers with and without chronic obstructive pulmonary disease. | Lowe KE et al. | โ | 2018 | โ |
| Association of thrombocytosis with COPD morbidity: the SPIROMICS and COPDGene cohorts. | Fawzy A et al. | โ | 2018 | โ |
| Asthma Is a Risk Factor for Respiratory Exacerbations Without Increased Rate of Lung Function Decline: Five-Year Follow-up in Adult Smokers From the COPDGene Study. | Hayden LP et al. | โ | 2018 | โ |
| Autocalibration method for non-stationary CT bias correction. | Vegas-Sรกnchez-Ferrero G et al. | โ | 2018 | โ |
| Automated Agatston Score Computation in non-ECG Gated CT Scans Using Deep Learning. | Cano-Espinosa C et al. | โ | 2018 | โ |
| Blood eosinophil count thresholds and exacerbations in patients with chronic obstructive pulmonary disease. | Yun JH et al. | โ | 2018 | โ |
| Bronchodilator responsiveness or reversibility in asthma and COPD - a need for clarity. | Barjaktarevic I et al. | โ | 2018 | โ |
| Centrilobular emphysema and coronary artery calcification: mediation analysis in the SPIROMICS cohort. | Bhatt SP et al. | โ | 2018 | โ |
| Childhood asthma is associated with COPD and known asthma variants in COPDGene: a genome-wide association study. | Hayden LP et al. | โ | 2018 | โ |
| Coronary Artery Calcium on Noncontrast Thoracic Computerized Tomography Scans and All-Cause Mortality. | Budoff MJ et al. | โ | 2018 | โ |
| CT-based Visual Classification of Emphysema: Association with Mortality in the COPDGene Study. | Lynch DA et al. | โ | 2018 | โ |
| CT densitometry in emphysema: a systematic review of its clinical utility. | Crossley D et al. | โ | 2018 | โ |
| CT-measured lung air-trapping is associated with higher carotid artery stiffness in individuals with chronic obstructive pulmonary disease. | Luehrs RE et al. | โ | 2018 | โ |
| CT measurements of central pulmonary vasculature as predictors of severe exacerbation in COPD. | Rho JY et al. | โ | 2018 | โ |
| Deep learning for biomarker regression: application to osteoporosis and emphysema on chest CT scans. | Gonzรกlez G et al. | โ | 2018 | โ |
| Defining Impaired Respiratory Health. A Paradigm Shift for Pulmonary Medicine. | Reyfman PA et al. | โ | 2018 | โ |
| Design and application of an MR reference phantom for multicentre lung imaging trials. | Triphan SMF et al. | โ | 2018 | โ |
| Development of a pulmonary imaging biomarker pipeline for phenotyping of chronic lung disease. | Guo F et al. | โ | 2018 | โ |
| Diffeomorphic Lung Registration Using Deep CNNs and Reinforced Learning. | Onieva JO et al. | โ | 2018 | โ |
| Disease Severity Dependence of the Longitudinal Association Between CT Lung Density and Lung Function in Smokers. | Diaz AA et al. | โ | 2018 | โ |
| Disease Staging and Prognosis in Smokers Using Deep Learning in Chest Computed Tomography. | Gonzรกlez G et al. | โ | 2018 | โ |
| Effect of smoking cessation on quantitative computed tomography in smokers at risk in a lung cancer screening population. | Jobst BJ et al. | โ | 2018 | โ |
| Elevated circulating MMP-9 is linked to increased COPD exacerbation risk in SPIROMICS and COPDGene. | Wells JM et al. | โ | 2018 | โ |
| Emphysematous and Nonemphysematous Gas Trapping in Chronic Obstructive Pulmonary Disease: Quantitative CT Findings and Pulmonary Function. | Occhipinti M et al. | โ | 2018 | โ |
| Features of COPD as Predictors of Lungย Cancer. | Carr LL et al. | โ | 2018 | โ |
| Genetic correlation between smoking behaviors and schizophrenia. | Hartz SM et al. | โ | 2018 | โ |
| Genetic variants predicting aerobic capacity response to training are also associated with skeletal muscle oxidative capacity in moderate-to-severe COPD. | Adami A et al. | โ | 2018 | โ |
| Genotype imputation performance of three reference panels using African ancestry individuals. | Vergara C et al. | โ | 2018 | โ |
| Grading Severity of Productive Cough Based on Symptoms and Airflow Obstruction. | Vazquez Guillamet R et al. | โ | 2018 | โ |
| Identification of Chronic Obstructive Pulmonary Disease Axes That Predict All-Cause Mortality: The COPDGene Study. | Kinney GL et al. | โ | 2018 | โ |
| Impact of advanced detector technology and iterative reconstruction on low-dose quantitative assessment of lung computed tomography density in a biological lung model. | Hammond E et al. | โ | 2018 | โ |
| Interstitial Features at Chest CT Enhance the Deleterious Effects of Emphysema in the COPDGene Cohort. | Ash SY et al. | โ | 2018 | โ |
| Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression. | Boueiz A et al. | โ | 2018 | โ |
| Longitudinal Modeling of Lung Function Trajectories in Smokers with and without Chronic Obstructive Pulmonary Disease. | Ross JC et al. | โ | 2018 | โ |
| Longitudinal Phenotypes and Mortality in Preserved Ratio Impaired Spirometry in the COPDGene Study. | Wan ES et al. | โ | 2018 | โ |
| Lung, Fat and Bone: Increased Adiponectin Associates with the Combination of Smoking-Related Lung Disease and Osteoporosis. | Suh YJ et al. | โ | 2018 | โ |
| Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD. | Cruickshank-Quinn CI et al. | โ | 2018 | โ |
| Morphological and functional properties of the conducting human airways investigated by in vivo computed tomography and in vitro MRI. | Van de Moortele T et al. | โ | 2018 | โ |
| Multiethnic meta-analysis identifies ancestry-specific and cross-ancestry loci for pulmonary function. | Wyss AB et al. | โ | 2018 | โ |
| Multiorgan structures detection using deep convolutional neural networks. | Onieva JO et al. | โ | 2018 | โ |
| Multi-structure Segmentation from Partially Labeled Datasets. Application to Body Composition Measurements on CT Scans. | Gonzรกlez G et al. | โ | 2018 | โ |
| New Spirometry Indices for Detecting Mild Airflow Obstruction. | Bhatt SP et al. | โ | 2018 | โ |
| On the Relevance of the Loss Function in the Agatston Score Regression from Non-ECG Gated CT Scans. | Cano-Espinosa C et al. | โ | 2018 | โ |
| Overfitting and Use of Mismatched Cohorts in Deep Learning Models: Preventable Design Limitations. | Mummadi SR et al. | โ | 2018 | โ |
| Paratracheal Paraseptal Emphysema and Expiratory Central Airway Collapse in Smokers. | Copeland CR et al. | โ | 2018 | โ |
| Pectoralis muscle area and mortality in smokers without airflow obstruction. | Diaz AA et al. | โ | 2018 | โ |
| Pulmonary Artery-Vein Classification in CT Images Using Deep Learning. | Nardelli P et al. | โ | 2018 | โ |
| Pulmonary quantitative CT imaging in focal and diffuse disease: current research and clinical applications. | Silva M et al. | โ | 2018 | โ |
| Pulmonary vascular pruning in smokers with bronchiectasis. | Diaz AA et al. | โ | 2018 | โ |
| Quantitative computed tomography phenotypes, spirometric parameters, and episodes of exacerbation in heavy smokers: An analysis from South America. | Barros MC et al. | โ | 2018 | โ |
| Race and Gender Disparities are Evident in COPD Underdiagnoses Across all Severities of Measured Airflow Obstruction. | Mamary AJ et al. | โ | 2018 | โ |
| Radiographic Emphysema, Circulating Bone Biomarkers, and Progressive Bone Mineral Density Loss in Smokers. | Bon J et al. | โ | 2018 | โ |
| Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer. | Liu Y et al. | โ | 2018 | โ |
| RNAseq analysis of bronchial epithelial cells to identify COPD-associated genes and SNPs. | Yeo J et al. | โ | 2018 | โ |
| Significance of Low-Attenuation Cluster Analysis on Quantitative CT in the Evaluation of Chronic Obstructive Pulmonary Disease. | Nambu A et al. | โ | 2018 | โ |
| Small airway segmentation in thoracic computed tomography scans: a machine learning approach. | Bian Z et al. | โ | 2018 | โ |
| Smoking duration alone provides stronger risk estimates of chronic obstructive pulmonary disease than pack-years. | Bhatt SP et al. | โ | 2018 | โ |
| Spirometric Volumes and Breathlessness across Levels of Airflow Limitation: The COPDGene Study. | Ekstrรถm M et al. | โ | 2018 | โ |
| Subject2Vec: Generative-Discriminative Approach from a Set of Image Patches to a Vector. | Singla S et al. | โ | 2018 | โ |
| Subjective cognitive complaints and neuropsychological performance in former smokers with and without chronic obstructive pulmonary disease. | Brunette AM et al. | โ | 2018 | โ |
| Systemic Markers of Adaptive and Innate Immunity Are Associated with Chronic Obstructive Pulmonary Disease Severity and Spirometric Disease Progression. | Halper-Stromberg E et al. | โ | 2018 | โ |
| Testing an optimally weighted combination of common and/or rare variants with multiple traits. | Wang Z et al. | โ | 2018 | โ |
| The Association Between Technology Use and Health Status in a Chronic Obstructive Pulmonary Disease Cohort: Multi-Method Study. | Witry M et al. | โ | 2018 | โ |
| The development of AZD7624 for prevention of exacerbations in COPD: a randomized controlled trial. | Patel NR et al. | โ | 2018 | โ |
| Total Airway Count on Computed Tomography and the Risk of Chronic Obstructive Pulmonary Disease Progression. Findings from a Population-based Study. | Kirby M et al. | โ | 2018 | โ |
| Transfer Learning for Multicenter Classification of Chronic Obstructive Pulmonary Disease. | Cheplygina V et al. | โ | 2018 | โ |
| Visual Estimate of Coronary Artery Calcium Predicts Cardiovascular Disease in COPD. | Bhatt SP et al. | โ | 2018 | โ |
| Whole exome sequencing analysis in severe chronic obstructive pulmonary disease. | Qiao D et al. | โ | 2018 | โ |
| Whole-Genome Sequencing in Severe Chronic Obstructive Pulmonary Disease. | Prokopenko D et al. | โ | 2018 | โ |
| Women manifest more severe COPD symptoms across the life course. | DeMeo DL et al. | โ | 2018 | โ |
| A Bayesian Nonparametric Model for Disease Subtyping: Application to Emphysema Phenotypes. | Ross JC et al. | โ | 2017 | โ |
| Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease. | Dransfield MT et al. | โ | 2017 | โ |
| A general approach to testing for pleiotropy with rare and common variants. | Lutz SM et al. | โ | 2017 | โ |
| A Likelihood-Free Approach for Characterizing Heterogeneous Diseases in Large-Scale Studies. | Schabdach J et al. | โ | 2017 | โ |
| Alpha-1 Antitrypsin PiMZ Genotype Is Associated with Chronic Obstructive Pulmonary Disease in Two Racial Groups. | Foreman MG et al. | โ | 2017 | โ |
| Association of sputum and blood eosinophil concentrations with clinical measures of COPD severity: an analysis of the SPIROMICS cohort. | Hastie AT et al. | โ | 2017 | โ |
| Asthma-chronic obstructive pulmonary disease overlap syndrome: a controversial concept. | Rodrigo GJ et al. | โ | 2017 | โ |
| Biomarkers of extracellular matrix turnover are associated with emphysema and eosinophilic-bronchitis in COPD. | Bihlet AR et al. | โ | 2017 | โ |
| Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts. | Keene JD et al. | โ | 2017 | โ |
| Biomechanical CT metrics are associated with patient outcomes in COPD. | Bodduluri S et al. | โ | 2017 | โ |
| Bronchoarterial ratio in never-smokers adults: Implications for bronchial dilation definition. | Diaz AA et al. | โ | 2017 | โ |
| Cardiac Morphometry on Computed Tomography and Exacerbation Reduction with ฮฒ-Blocker Therapy in Chronic Obstructive Pulmonary Disease. | Bhatt SP et al. | โ | 2017 | โ |
| Chest computed tomography-derived lowย fat-free mass index and mortality inย COPD. | McDonald MN et al. | โ | 2017 | โ |
| Chronic obstructive pulmonary disease is independently associated with hypertension in men: A survey design analysis using nationwide survey data. | Kim SH et al. | โ | 2017 | โ |
| Clinical and Genetic Associations of Objectively Identified Interstitial Changes inย Smokers. | Ash SY et al. | โ | 2017 | โ |
| Comparison of low- and ultralow-dose computed tomography protocols for quantitative lung and airway assessment. | Hammond E et al. | โ | 2017 | โ |
| Computed Tomography Measure of Lung at Risk and Lung Function Decline in Chronic Obstructive Pulmonary Disease. | Bhatt SP et al. | โ | 2017 | โ |
| Computed tomography quantification of tracheal abnormalities in COPD and their influence on airflow limitation. | Gallardo Estrella L et al. | โ | 2017 | โ |
| CT-Based Local Distribution Metric Improves Characterization of COPD. | Hoff BA et al. | โ | 2017 | โ |
| CT Image Enhancement for Feature Detection and Localization. | Nardelli P et al. | โ | 2017 | โ |
| CT imaging of chronic obstructive pulmonary disease: insights, disappointments, and promise. | Washko GR et al. | โ | 2017 | โ |
| CT Quantification of Lungs and Airways in Normal Korean Subjects. | Kim SS et al. | โ | 2017 | โ |
| Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts. | Castaldi PJ et al. | โ | 2017 | โ |
| Electronic Cigarette Use in US Adults at Risk for or with COPD: Analysis from Two Observational Cohorts. | Bowler RP et al. | โ | 2017 | โ |
| Emerging inhaled long-acting beta-2 adrenoceptor agonists for the treatment of COPD. | Monaco TJ et al. | โ | 2017 | โ |
| Estimating drivers of cell state transitions using gene regulatory network models. | Schlauch D et al. | โ | 2017 | โ |
| Examination of the Involvement of Cholinergic-Associated Genes in Nicotine Behaviors in European and African Americans. | Melroy-Greif WE et al. | โ | 2017 | โ |
| Examining the Effects of Age on Health Outcomes of Chronic Obstructive Pulmonary Disease: Results From the Genetic Epidemiology of Chronic Obstructive Pulmonary Disease Study and Evaluation of Chronic Obstructive Pulmonary Disease Longitudinally to Identify Predictive Surrogate Endpoints Cohorts. | Parulekar AD et al. | โ | 2017 | โ |
| Exclusion of emphysematous lung from dose-volume estimates of risk improves prediction of radiation pneumonitis. | Uchida Y et al. | โ | 2017 | โ |
| External Validation of the COmorbidity Test. | Villalobos N et al. | โ | 2017 | โ |
| GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease. | Martinez CH et al. | โ | 2017 | โ |
| Genetic Association and Risk Scores in a Chronic Obstructive Pulmonary Disease Meta-analysis of 16,707 Subjects. | Busch R et al. | โ | 2017 | โ |
| Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. | Wain LV et al. | โ | 2017 | โ |
| Genome-wide genetic heterogeneity discovery with categorical covariates. | Llinares-Lรณpez F et al. | โ | 2017 | โ |
| Handgrip Strength in Chronic Obstructive Pulmonary Disease. Associations with Acute Exacerbations and Body Composition. | Martinez CH et al. | โ | 2017 | โ |
| Higher BMI is associated with higher expiratory airflow normalised for lung volume (FEF25-75/FVC) in COPD. | Abston E et al. | โ | 2017 | โ |
| Improving airway segmentation in computed tomography using leak detection with convolutional networks. | Charbonnier JP et al. | โ | 2017 | โ |
| Inhaled Steroids and Active Smoking Drive Chronic Obstructive Pulmonary Disease Symptoms and Biomarkers to a Greater Degree Than Airflow Limitation. | Silkoff PE et al. | โ | 2017 | โ |
| Lung Mass in Smokers. | Washko GR et al. | โ | 2017 | โ |
| Management of COPD: Is there a role for quantitative imaging? | Kirby M et al. | โ | 2017 | โ |
| Manifold Learning of COPD. | Bragman FJS et al. | โ | 2017 | โ |
| Meta-analysis of peripheral blood gene expression modules for COPD phenotypes. | Reinhold D et al. | โ | 2017 | โ |
| Metabolomic similarities between bronchoalveolar lavage fluid and plasma in humans and mice. | Cruickshank-Quinn C et al. | โ | 2017 | โ |
| Mortality prediction in idiopathic pulmonary fibrosis: evaluation of computer-based CT analysis with conventional severity measures. | Jacob J et al. | โ | 2017 | โ |
| Multiple biomarkers predict disease severity, progression and mortality in COPD. | Zemans RL et al. | โ | 2017 | โ |
| Neutrophil-mediated IL-6 receptor trans-signaling and the risk of chronic obstructive pulmonary disease and asthma. | Farahi N et al. | โ | 2017 | โ |
| Obesity Is Associated With Increased Morbidity in Moderate to Severe COPD. | Lambert AA et al. | โ | 2017 | โ |
| Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources. | Hoogendoorn M et al. | โ | 2017 | โ |
| Predictive value of prebronchodilator and postbronchodilator spirometry for COPD features and outcomes. | Fortis S et al. | โ | 2017 | โ |
| Pulmonary Lobe Segmentation With Probabilistic Segmentation of the Fissures and a Groupwise Fissure Prior. | Bragman FJS et al. | โ | 2017 | โ |
| Quantitative CT Measures of Bronchiectasis in Smokers. | Diaz AA et al. | โ | 2017 | โ |
| Reproducibility of NIRS assessment of muscle oxidative capacity in smokers with and without COPD. | Adami A et al. | โ | 2017 | โ |
| RNA sequencing identifies novel non-coding RNA and exon-specific effects associated with cigarette smoking. | Parker MM et al. | โ | 2017 | โ |
| Role of dual bronchodilators in COPD: A review of the current evidence for indacaterol/glycopyrronium. | Ficker JH et al. | โ | 2017 | โ |
| [Severity classification of chronic obstructive pulmonary disease based on deep learning]. | Ying J et al. | โ | 2017 | โ |
| Sex-Based Genetic Association Study Identifies CELSR1 as a Possible Chronic Obstructive Pulmonary Disease Risk Locus among Women. | Hardin M et al. | โ | 2017 | โ |
| Signs of Gas Trapping in Normal Lung Density Regions in Smokers. | Bodduluri S et al. | โ | 2017 | โ |
| Susceptibility to Childhood Pneumonia: A Genome-Wide Analysis. | Hayden LP et al. | โ | 2017 | โ |
| The Contribution of Small Airway Obstruction to the Pathogenesis of Chronic Obstructive Pulmonary Disease. | Hogg JC et al. | โ | 2017 | โ |
| The COPD Biomarkers Qualification Consortium Database: Baseline Characteristics of the St George's Respiratory Questionnaire Dataset. | Tabberer M et al. | โ | 2017 | โ |
| The diagnosis of idiopathic pulmonary fibrosis: current and future approaches. | Martinez FJ et al. | โ | 2017 | โ |
| The effects of iterative reconstruction and kernel selection on quantitative computed tomography measures of lung density. | Rodriguez A et al. | โ | 2017 | โ |
| The <i>MUC5B</i> promoter polymorphism is associated with specific interstitial lung abnormality subtypes. | Putman RK et al. | โ | 2017 | โ |
| The Objective Identification and Quantification of Interstitial Lung Abnormalities in Smokers. | Ash SY et al. | โ | 2017 | โ |
| The value of blood cytokines and chemokines in assessing COPD. | Bradford E et al. | โ | 2017 | โ |
| Through the Looking Glass and What Was Found There: Imaging Biomarkers of Chronic Obstructive Pulmonary Disease. | Capaldi DPI et al. | โ | 2017 | โ |
| Ventricular Geometry From Non-contrast Non-ECG-gated CT Scans: An Imaging Marker of Cardiopulmonary Disease in Smokers. | Rahaghi FN et al. | โ | 2017 | โ |
| Visual Assessment of Chest Computed Tomographic Images Is Independently Useful for Genetic Association Analysis in Studies of Chronic Obstructive Pulmonary Disease. | Halper-Stromberg E et al. | โ | 2017 | โ |
| A General and Robust Framework for Secondary Traits Analysis. | Song X et al. | โ | 2016 | โ |
| A genome-wide analysis of the response to inhaled ฮฒ2-agonists in chronic obstructive pulmonary disease. | Hardin M et al. | โ | 2016 | โ |
| Age-Related Differences in Health-Related Quality of Life in COPD: An Analysis of the COPDGene and SPIROMICS Cohorts. | Martinez CH et al. | โ | 2016 | โ |
| An Adaptive Fisher's Combination Method for Joint Analysis of Multiple Phenotypes in Association Studies. | Liang X et al. | โ | 2016 | โ |
| Analysis of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Defined on the Basis of Bronchodilator Response and Degree of Emphysema. | Cosentino J et al. | โ | 2016 | โ |
| A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria. | Dilektasli AG et al. | โ | 2016 | โ |
| A phase III randomised controlled trial of single-dose triple therapy in COPD: the IMPACT protocol. | Pascoe SJ et al. | โ | 2016 | โ |
| A Robust Emphysema Severity Measure Based on Disease Subtypes. | Harmouche R et al. | โ | 2016 | โ |
| Arterial and Venous Pulmonary Vascular Morphology and Their Relationship to Findings in Cardiac Magnetic Resonance Imaging in Smokers. | Rahaghi FN et al. | โ | 2016 | โ |
| Association Between Expiratory Central Airway Collapse and Respiratory Outcomes Among Smokers. | Bhatt SP et al. | โ | 2016 | โ |
| Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. | Bhatt SP et al. | โ | 2016 | โ |
| Association Between Interstitial Lung Abnormalities and All-Cause Mortality. | Putman RK et al. | โ | 2016 | โ |
| Association of Single Nucleotide Polymorphisms of PADI4 and HLA-DRB1 Alleles with Susceptibility to Rheumatoid Arthritis-Related Lung Diseases. | Song ST et al. | โ | 2016 | โ |
| AUTOMATED AGATSTON SCORE COMPUTATION IN A LARGE DATASET OF NON ECG-GATED CHEST COMPUTED TOMOGRAPHY. | Gonzรกlez G et al. | โ | 2016 | โ |
| Automatic Synthesis of Anthropomorphic Pulmonary CT Phantoms. | Jimenez-Carretero D et al. | โ | 2016 | โ |
| Biomarkers of early chronic obstructive pulmonary disease (COPD) in smokers and former smokers. Protocol of a longitudinal study. | Truedsson M et al. | โ | 2016 | โ |
| Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study. | Wells JM et al. | โ | 2016 | โ |
| Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. | Sun W et al. | โ | 2016 | โ |
| Computed Tomographic Airway Morphology in Chronic Obstructive Pulmonary Disease. Remodeling or Innate Anatomy? | Diaz AA et al. | โ | 2016 | โ |
| Computed Tomography Image Matching in Chronic Obstructive Pulmonary Disease. | Bodduluri S et al. | โ | 2016 | โ |
| COPD subtypes identified by network-based clustering of blood gene expression. | Chang Y et al. | โ | 2016 | โ |
| CT-derived Biomechanical Metrics Improve Agreement Between Spirometry and Emphysema. | Bhatt SP et al. | โ | 2016 | โ |
| Current situation of asthma-COPD overlap syndrome (ACOS) in Chinese patients older than 40 years with airflow limitation: rationale and design for a multicenter, cross-sectional trial (study protocol). | Kang J et al. | โ | 2016 | โ |
| Current Smoking Status Is Associated With Lower Quantitative CT Measures of Emphysema and Gas Trapping. | Zach JA et al. | โ | 2016 | โ |
| Desmoplakin Variants Are Associated with Idiopathic Pulmonary Fibrosis. | Mathai SK et al. | โ | 2016 | โ |
| Differences between absolute and predicted values of forced expiratory volumes to classify ventilatory impairment in chronic obstructive pulmonary disease. | Checkley W et al. | โ | 2016 | โ |
| Effect of Emphysema Severity on the Apnea-Hypopnea Index in Smokers with Obstructive Sleep Apnea. | Krachman SL et al. | โ | 2016 | โ |
| Epidemiology of Chronic Obstructive Pulmonary Disease (COPD) in Aging Populations. | Fragoso CA | โ | 2016 | โ |
| Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease. | Qiao D et al. | โ | 2016 | โ |
| Extended Modality Propagation: Image Synthesis of Pathological Cases. | Cordier N et al. | โ | 2016 | โ |
| Genome-wide imputation study identifies novel HLA locus for pulmonary fibrosis and potential role for auto-immunity in fibrotic idiopathic interstitial pneumonia. | Fingerlin TE et al. | โ | 2016 | โ |
| Hemizygous Deletion on Chromosome 3p26.1 Is Associated with Heavy Smoking among African American Subjects in the COPDGene Study. | Begum F et al. | โ | 2016 | โ |
| Identifying a Deletion Affecting Total Lung Capacity Among Subjects in the COPDGene Study Cohort. | Begum F et al. | โ | 2016 | โ |
| Imaging biomarkers in the clinic. | van Beek EJ | โ | 2016 | โ |
| Inflammatory triggers associated with exacerbations of COPD orchestrate plasticity of group 2 innate lymphoid cells in the lungs. | Silver JS et al. | โ | 2016 | โ |
| Insight into Best Variables for COPD Case Identification: A Random Forests Analysis. | Leidy NK et al. | โ | 2016 | โ |
| Lung Tissue Volume is Elevated in Obesity and Reduced by Bariatric Surgery. | Santos A et al. | โ | 2016 | โ |
| Lung VITAL: Rationale, design, and baseline characteristics of an ancillary study evaluating the effects of vitamin D and/or marine omega-3 fatty acid supplements on acute exacerbations of chronic respiratory disease, asthma control, pneumonia and lung function in adults. | Gold DR et al. | โ | 2016 | โ |
| Lymphocyte Kv1.3-channels in the pathogenesis of chronic obstructive pulmonary disease: novel therapeutic implications of targeting the channels by commonly used drugs. | Kazama I et al. | โ | 2016 | โ |
| Meeting the challenge of COPD care delivery in the USA: a multiprovider perspective. | Han MK et al. | โ | 2016 | โ |
| Multiplanar MDCT measurement of esophageal hiatus surface area: association with hiatal hernia and GERD. | Ouyang W et al. | โ | 2016 | โ |
| Normalizing computed tomography data reconstructed with different filter kernels: effect on emphysema quantification. | Gallardo-Estrella L et al. | โ | 2016 | โ |
| Panlobular Emphysema: Enhancing Visibility with Quantitative Computed Tomography. | Bhatt SP | โ | 2016 | โ |
| Parametric Response Mapping of Bronchiolitis Obliterans Syndrome Progression After Lung Transplantation. | Verleden SE et al. | โ | 2016 | โ |
| Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease. | Kim V et al. | โ | 2016 | โ |
| Phenotype of Spirometric Impairment in an Aging Population. | Vaz Fragoso CA et al. | โ | 2016 | โ |
| Plasma Fibrinogen Qualification as a Drug Development Tool in Chronic Obstructive Pulmonary Disease. Perspective of the Chronic Obstructive Pulmonary Disease Biomarker Qualification Consortium. | Miller BE et al. | โ | 2016 | โ |
| Post-GWAS Prioritization Through Data Integration Provides Novel Insights on Chronic Obstructive Pulmonary Disease. | Lu Q et al. | โ | 2016 | โ |
| Pulmonary CT and MRI phenotypes that help explain chronic pulmonary obstruction disease pathophysiology and outcomes. | Hoffman EA et al. | โ | 2016 | โ |
| Pulmonary Predictors of Incident Diabetes in Smokers. | Kinney GL et al. | โ | 2016 | โ |
| Quantitative computed tomography imaging in chronic obstructive pulmonary disease. | Fernandes L et al. | โ | 2016 | โ |
| Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease. | Nambu A et al. | โ | 2016 | โ |
| Quantitative Dual-Energy Computed Tomography Supports a Vascular Etiology of Smoking-induced Inflammatory Lung Disease. | Iyer KS et al. | โ | 2016 | โ |
| Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. | Busch R et al. | โ | 2016 | โ |
| Sex-specific features of emphysema among current and former smokers with COPD. | Hardin M et al. | โ | 2016 | โ |
| SPIROMICS Protocol for Multicenter Quantitative Computed Tomography to Phenotype the Lungs. | Sieren JP et al. | โ | 2016 | โ |
| Study Design and Interim Outcomes of Guangzhou Institute of Respiratory Disease COPD Biobank. | Lu W et al. | โ | 2016 | โ |
| Texture-based Quantification of Centrilobular Emphysema and Centrilobular Nodularity in Longitudinal CT Scans of Current and Former Smokers. | Ginsburg SB et al. | โ | 2016 | โ |
| The role of air pollution in COPD and implications for therapy. | Lopez-Campos JL et al. | โ | 2016 | โ |
| This is what COPD looks like. | Sheikh K et al. | โ | 2016 | โ |
| Unsupervised Discovery of Emphysema Subtypes in a Large Clinical Cohort. | Binder P et al. | โ | 2016 | โ |
| Ventilation Heterogeneity in Never-smokers and COPD:: Comparison of Pulmonary Functional Magnetic Resonance Imaging with the Poorly Communicating Fraction Derived From Plethysmography. | Davis C et al. | โ | 2016 | โ |
| ฮฒ-Blockers are associated with a reduction in COPD exacerbations. | Bhatt SP et al. | โ | 2016 | โ |
| Abdominal Visceral Adipose Tissue is Associated with Myocardial Infarction in Patients with COPD. | Diaz AA et al. | โ | 2015 | โ |
| A Feature-Based Approach to Big Data Analysis of Medical Images. | Toews M et al. | โ | 2015 | โ |
| A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. | Lutz SM et al. | โ | 2015 | โ |
| A genome-wide association study of chronic obstructive pulmonary disease in Hispanics. | Chen W et al. | โ | 2015 | โ |
| A Genome-Wide Association Study of Emphysema and Airway Quantitative Imaging Phenotypes. | Cho MH et al. | โ | 2015 | โ |
| Automated quantitative 3D analysis of aorta size, morphology, and mural calcification distributions. | Kurugol S et al. | โ | 2015 | โ |
| Biomarkers for precision medicine in airways disease. | Rooney C et al. | โ | 2015 | โ |
| CD4+ T-Cell Profiles and Peripheral Blood Ex-Vivo Responses to T-Cell Directed Stimulation Delineate COPD Phenotypes. | Roberts MEP et al. | โ | 2015 | โ |
| Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study. | Hayden LP et al. | โ | 2015 | โ |
| Chronic obstructive pulmonary disease and subsequent overall and lung cancer mortality in low-income adults. | Aldrich MC et al. | โ | 2015 | โ |
| Chronic Obstructive Pulmonary Disease: Pulmonary Function and CT Lung Attenuation Do Not Show Linear Correlation. | Paoletti M et al. | โ | 2015 | โ |
| Clinical and Immunological Factors in Emphysema Progression. Five-Year Prospective Longitudinal Exacerbation Study of Chronic Obstructive Pulmonary Disease (LES-COPD). | Bhavani S et al. | โ | 2015 | โ |
| Clinical and Radiologic Disease in Smokers With Normal Spirometry. | Regan EA et al. | โ | 2015 | โ |
| Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. | Kim V et al. | โ | 2015 | โ |
| Comparison of acute respiratory events between asthma-COPD overlap syndrome and COPD patients: a population-based cohort study. | Chung WS et al. | โ | 2015 | โ |
| COPD: Do Imaging Measurements of Emphysema and Airway Disease Explain Symptoms and Exercise Capacity? | Kirby M et al. | โ | 2015 | โ |
| CT-Definable Subtypes of Chronic Obstructive Pulmonary Disease: A Statement of the Fleischner Society. | Lynch DA et al. | โ | 2015 | โ |
| Detailed analysis of the density change on chest CT of COPD using non-rigid registration of inspiration/expiration CT scans. | Kim EY et al. | โ | 2015 | โ |
| Disability in moderate chronic obstructive pulmonary disease: prevalence, burden and assessment - results from a real-life study. | Braido F et al. | โ | 2015 | โ |
| Dissecting the genetics of chronic mucus hypersecretion in smokers with and without COPD. | Dijkstra AE et al. | โ | 2015 | โ |
| Early chronic obstructive pulmonary disease: definition, assessment, and prevention. | Rennard SI et al. | โ | 2015 | โ |
| Functional lung MRI in chronic obstructive pulmonary disease: comparison of T1 mapping, oxygen-enhanced T1 mapping and dynamic contrast enhanced perfusion. | Jobst BJ et al. | โ | 2015 | โ |
| Generative Method to Discover Genetically Driven Image Biomarkers. | Batmanghelich NK et al. | โ | 2015 | โ |
| Genome-wide association study revealed a promising region and candidate genes for eggshell quality in an F2 resource population. | Sun C et al. | โ | 2015 | โ |
| Genome-wide meta-analysis reveals common splice site acceptor variant in CHRNA4 associated with nicotine dependence. | Hancock DB et al. | โ | 2015 | โ |
| Genome-wide site-specific differential methylation in the blood of individuals with Klinefelter syndrome. | Wan ES et al. | โ | 2015 | โ |
| Improved pulmonary nodule classification utilizing quantitative lung parenchyma features. | Dilger SK et al. | โ | 2015 | โ |
| Integrating Multiple Correlated Phenotypes for Genetic Association Analysis by Maximizing Heritability. | Zhou JJ et al. | โ | 2015 | โ |
| IREB2 and GALC are associated with pulmonary artery enlargement in chronic obstructive pulmonary disease. | Lee JH et al. | โ | 2015 | โ |
| Large trials, new knowledge: the changing face of COPD management. | De Soyza A et al. | โ | 2015 | โ |
| Menthol cigarette smoking in the COPDGene cohort: relationship with COPD, comorbidities and CT metrics. | Park SJ et al. | โ | 2015 | โ |
| Mortality prediction in chronic obstructive pulmonary disease comparing the GOLD 2007 and 2011 staging systems: a pooled analysis of individual patient data. | Soriano JB et al. | โ | 2015 | โ |
| Occupational exposures and chronic obstructive pulmonary disease. Causality established, time to focus on effect and phenotypes. | Martinez CH et al. | โ | 2015 | โ |
| Patterns of Emphysema Heterogeneity. | Valipour A et al. | โ | 2015 | โ |
| Phenotype of normal spirometry in an aging population. | Vaz Fragoso CA et al. | โ | 2015 | โ |
| Plasma sphingolipids associated with chronic obstructive pulmonary disease phenotypes. | Bowler RP et al. | โ | 2015 | โ |
| Prevalence and global initiative for chronic obstructive lung disease group distribution of chronic obstructive pulmonary disease detected by preoperative pulmonary function test. | Choi SM et al. | โ | 2015 | โ |
| Pulmonary abnormalities and carotid atherosclerosis in ex-smokers without airflow limitation. | Pike D et al. | โ | 2015 | โ |
| Pulmonary artery enlargement is associated with right ventricular dysfunction and loss of blood volume in small pulmonary vessels in chronic obstructive pulmonary disease. | Wells JM et al. | โ | 2015 | โ |
| Quantitative Assessment of Global and Regional Air Trappings Using Non-Rigid Registration and Regional Specific Volume Change of Inspiratory/Expiratory CT Scans: Studies on Healthy Volunteers and Asthmatics. | Lee E et al. | โ | 2015 | โ |
| Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. | Jaramillo JD et al. | โ | 2015 | โ |
| Right ventricular diastolic function and exercise capacity in COPD. | Fenster BE et al. | โ | 2015 | โ |
| Secondhand Tobacco Smoke and COPD Risk in Smokers: A COPDGene Study Cohort Subgroup Analysis. | van Koeverden I et al. | โ | 2015 | โ |
| Significance of Medication History at the Time of Entry into the COPDGene Study: Relationship with Exacerbation and CT Metrics. | Park SJ et al. | โ | 2015 | โ |
| Smoking-Associated Site-Specific Differential Methylation in Buccal Mucosa in the COPDGene Study. | Wan ES et al. | โ | 2015 | โ |
| Telomerase mutations in smokers with severe emphysema. | Stanley SE et al. | โ | 2015 | โ |
| The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications. | Kim V et al. | โ | 2015 | โ |
| The impact of genetic variation and cigarette smoke on DNA methylation in current and former smokers from the COPDGene study. | Qiu W et al. | โ | 2015 | โ |
| The Impact of Sources of Variability on Parametric Response Mapping of Lung CT Scans. | Boes JL et al. | โ | 2015 | โ |
| The Swedish CArdioPulmonary BioImage Study: objectives and design. | Bergstrรถm G et al. | โ | 2015 | โ |
| Ultra-short echo-time pulmonary MRI: evaluation and reproducibility in COPD subjects with and without bronchiectasis. | Ma W et al. | โ | 2015 | โ |
| Understanding the contribution of native tracheobronchial structure to lung function: CT assessment of airway morphology in never smokers. | Diaz AA et al. | โ | 2015 | โ |
| Acute Exacerbation and Respiratory InfectionS in COPD (AERIS): protocol for a prospective, observational cohort study. | Bourne S et al. | โ | 2014 | โ |
| A Decade of National Heart, Lung, and Blood Institute Programs Supporting COPD Research and Education . | Postow L et al. | โ | 2014 | โ |
| Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study. | Parker MM et al. | โ | 2014 | โ |
| Airway wall thickness is increased in COPD patients with bronchodilator responsiveness. | Kim V et al. | โ | 2014 | โ |
| Analyzing networks of phenotypes in complex diseases: methodology and applications in COPD. | Chu JH et al. | โ | 2014 | โ |
| A simplified score to quantify comorbidity in COPD. | Putcha N et al. | โ | 2014 | โ |
| Association between occupational exposure and lung function, respiratory symptoms, and high-resolution computed tomography imaging in COPDGene. | Marchetti N et al. | โ | 2014 | โ |
| Beyond GWAS in COPD: probing the landscape between gene-set associations, genome-wide associations and protein-protein interaction networks. | McDonald ML et al. | โ | 2014 | โ |
| Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. | Black-Shinn JL et al. | โ | 2014 | โ |
| Childhood-onset asthma in smokers. association between CT measures of airway size, lung function, and chronic airflow obstruction. | Diaz AA et al. | โ | 2014 | โ |
| Circulating hematopoietic progenitor cells are decreased in COPD. | Janssen WJ et al. | โ | 2014 | โ |
| Clinical and computed tomographic predictors of chronic bronchitis in COPD: a cross sectional analysis of the COPDGene study. | Kim V et al. | โ | 2014 | โ |
| Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. | Castaldi PJ et al. | โ | 2014 | โ |
| Common genetic variants associated with resting oxygenation in chronic obstructive pulmonary disease. | McDonald ML et al. | โ | 2014 | โ |
| Comorbidities of COPD have a major impact on clinical outcomes, particularly in African Americans. | Putcha N et al. | โ | 2014 | โ |
| Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. | Bhatt SP et al. | โ | 2014 | โ |
| Computed tomographic measures of airway morphology in smokers and never-smoking normals. | Washko GR et al. | โ | 2014 | โ |
| Computing global minimizers to a constrained B-spline image registration problem from optimal l1 perturbations to block match data. | Castillo E et al. | โ | 2014 | โ |
| Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). | Couper D et al. | โ | 2014 | โ |
| Disproportionate contribution of right middle lobe to emphysema and gas trapping on computed tomography. | Bhatt SP et al. | โ | 2014 | โ |
| DNAH5 is associated with total lung capacity in chronic obstructive pulmonary disease. | Lee JH et al. | โ | 2014 | โ |
| Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. | Wan ES et al. | โ | 2014 | โ |
| FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices. | Bhatt SP et al. | โ | 2014 | โ |
| Genetic susceptibility for chronic bronchitis in chronic obstructive pulmonary disease. | Lee JH et al. | โ | 2014 | โ |
| Genome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patterns. | Castaldi PJ et al. | โ | 2014 | โ |
| Hyperpolarized 3He and 129Xe magnetic resonance imaging apparent diffusion coefficients: physiological relevance in older never- and ex-smokers. | Kirby M et al. | โ | 2014 | โ |
| Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. | Martinez CH et al. | โ | 2014 | โ |
| Integrative genomics of chronic obstructive pulmonary disease. | Hobbs BD et al. | โ | 2014 | โ |
| Lessons from ECLIPSE: a review of COPD biomarkers. | Faner R et al. | โ | 2014 | โ |
| Longitudinal Computed Tomography and Magnetic Resonance Imaging of COPD: Thoracic Imaging Network of Canada (TINCan) Study Objectives. | Kirby M et al. | โ | 2014 | โ |
| MDR-1 gene C/T polymorphism in COPD: data from Aegean part of Turkey. | Toru U et al. | โ | 2014 | โ |
| Multidetector computed tomographic imaging in chronic obstructive pulmonary disease: emphysema and airways assessment. | Litmanovich DE et al. | โ | 2014 | โ |
| Multi-scale analysis of imaging features and its use in the study of COPD exacerbation susceptible phenotypes. | Bragman FJ et al. | โ | 2014 | โ |
| New developments in the assessment of COPD: early diagnosis is key. | Csikesz NG et al. | โ | 2014 | โ |
| Non-emphysematous chronic obstructive pulmonary disease is associated with diabetes mellitus. | Hersh CP et al. | โ | 2014 | โ |
| On the simultaneous association analysis of large genomic regions: a massive multi-locus association test. | Qiao D et al. | โ | 2014 | โ |
| Parametric response mapping as an indicator of bronchiolitis obliterans syndrome after hematopoietic stem cell transplantation. | Galbรกn CJ et al. | โ | 2014 | โ |
| Personalized medicine for chronic, complex diseases: chronic obstructive pulmonary disease as an example. | Radder JE et al. | โ | 2014 | โ |
| Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene. | Lee JH et al. | โ | 2014 | โ |
| Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease. | Hobbs BD et al. | โ | 2014 | โ |
| Prediction of acute respiratory disease in current and former smokers with and without COPD. | Bowler RP et al. | โ | 2014 | โ |
| Progress in Imaging COPD, 2004 - 2014. | Lynch DA | โ | 2014 | โ |
| Pulmonary 3 T MRI with ultrashort TEs: influence of ultrashort echo time interval on pulmonary functional and clinical stage assessments of smokers. | Ohno Y et al. | โ | 2014 | โ |
| Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. | Kinney GL et al. | โ | 2014 | โ |
| Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. | McDonald ML et al. | โ | 2014 | โ |
| Radiological correlates and clinical implications of the paradoxical lung function response to ฮฒโ agonists: an observational study. | Bhatt SP et al. | โ | 2014 | โ |
| Risk Factors for Venous Thromboembolism in Chronic Obstructive Pulmonary Disease. | Kim V et al. | โ | 2014 | โ |
| Risk loci for chronic obstructive pulmonary disease: a genome-wide association study and meta-analysis. | Cho MH et al. | โ | 2014 | โ |
| Roflumilast : the new orally active, selective phophodiesterase-4 inhibitor, for the treatment of COPD. | Tashkin DP | โ | 2014 | โ |
| Sinogram Affirmed Iterative Reconstruction (SAFIRE) versus weighted filtered back projection (WFBP) effects on quantitative measure in the COPDGene 2 test object. | Sieren JP et al. | โ | 2014 | โ |
| Spherical Topic Models for Imaging Phenotype Discovery in Genetic Studies. | Batmanghelich KN et al. | โ | 2014 | โ |
| Susceptibility to chronic mucus hypersecretion, a genome wide association study. | Dijkstra AE et al. | โ | 2014 | โ |
| The association of plasma biomarkers with computed tomography-assessed emphysema phenotypes. | Carolan BJ et al. | โ | 2014 | โ |
| The clinical and genetic features of COPD-asthma overlap syndrome. | Hardin M et al. | โ | 2014 | โ |
| The clinical impact of non-obstructive chronic bronchitis in current and former smokers. | Martinez CH et al. | โ | 2014 | โ |
| Variation of densitometry on computed tomography in COPD--influence of different software tools. | Wielpรผtz MO et al. | โ | 2014 | โ |
| Visual Assessment of CT Findings in Smokers With Nonobstructed Spirometric Abnormalities in The COPDGene<sup>ยฎ</sup> Study. | Kim SS et al. | โ | 2014 | โ |
| A general semi-parametric approach to the analysis of genetic association studies in population-based designs. | Lutz S et al. | โ | 2013 | โ |
| A reference dataset for deformable image registration spatial accuracy evaluation using the COPDgene study archive. | Castillo R et al. | โ | 2013 | โ |
| Biomarkers that predict and guide therapy for exacerbations of chronic obstructive pulmonary disease. | Brightling CE | โ | 2013 | โ |
| Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort. | Agusti A et al. | โ | 2013 | โ |
| Characterizing functional lung heterogeneity in COPD using reference equations for CT scan-measured lobar volumes. | Come CE et al. | โ | 2013 | โ |
| Chronic obstructive pulmonary disease. Are the times changing? | Almagro P et al. | โ | 2013 | โ |
| Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by Using standard images--comparison with quantitative CT and pulmonary function test in the COPDGene study. | Kim SS et al. | โ | 2013 | โ |
| Chronic obstructive pulmonary disease: more imaging, more phenotyping...better care? | Pike D et al. | โ | 2013 | โ |
| Clinical phenotypes of chronic obstructive pulmonary disease and asthma: recent advances. | Carolan BJ et al. | โ | 2013 | โ |
| Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications. | Estรฉpar RS et al. | โ | 2013 | โ |
| Computed tomography density histogram analysis to evaluate pulmonary emphysema in ex-smokers. | Owrangi AM et al. | โ | 2013 | โ |
| Dissecting direct and indirect genetic effects on chronic obstructive pulmonary disease (COPD) susceptibility. | Siedlinski M et al. | โ | 2013 | โ |
| Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers. | Castaldi PJ et al. | โ | 2013 | โ |
| Effect of emphysema on CT scan measures of airway dimensions in smokers. | Diaz AA et al. | โ | 2013 | โ |
| FAQs about the GOLD 2011 assessment proposal of COPD: a comparative analysis of four different cohorts. | Agusti A et al. | โ | 2013 | โ |
| Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. | Fingerlin TE et al. | โ | 2013 | โ |
| GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. | Han MK et al. | โ | 2013 | โ |
| Heritability of chronic obstructive pulmonary disease and related phenotypes in smokers. | Zhou JJ et al. | โ | 2013 | โ |
| Heterogeneity of chronic obstructive pulmonary disease: from phenotype to genotype. | Chen X et al. | โ | 2013 | โ |
| Integrative omics approach identifies interleukin-16 as a biomarker of emphysema. | Bowler RP et al. | โ | 2013 | โ |
| Nitric oxide synthase polymorphisms, gene expression and lung function in chronic obstructive pulmonary disease. | Aminuddin F et al. | โ | 2013 | โ |
| Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. | Hersh CP et al. | โ | 2013 | โ |
| Pathophysiology and clinical implications of pulmonary arterial enlargement in COPD. | Wells JM et al. | โ | 2013 | โ |
| Peripheral blood mononuclear cell gene expression in chronic obstructive pulmonary disease. | Bahr TM et al. | โ | 2013 | โ |
| Phenotyping the heterogeneity of chronic obstructive pulmonary disease. | Barker BL et al. | โ | 2013 | โ |
| Pulmonary emphysema in cystic fibrosis detected by densitometry on chest multidetector computed tomography. | Wielpรผtz MO et al. | โ | 2013 | โ |
| Pulmonary lobe segmentation based on ridge surface sampling and shape model fitting. | Ross JC et al. | โ | 2013 | โ |
| Quantification and Analysis of Large Multimodal Clinical Image Studies: Application to Stroke. | Sridharan R et al. | โ | 2013 | โ |
| Quantitative computed tomography in chronic obstructive pulmonary disease. | Lynch DA et al. | โ | 2013 | โ |
| Quantitative thoracic CT techniques in adults: can they be applied in the pediatric population? | Yoon SH et al. | โ | 2013 | โ |
| Racial differences in CT phenotypes in COPD. | Hansel NN et al. | โ | 2013 | โ |
| Registration-based lung mechanical analysis of chronic obstructive pulmonary disease (COPD) using a supervised machine learning framework. | Bodduluri S et al. | โ | 2013 | โ |
| Relationships between airflow obstruction and quantitative CT measurements of emphysema, air trapping, and airways in subjects with and without chronic obstructive pulmonary disease. | Schroeder JD et al. | โ | 2013 | โ |
| Semi-automated scoring of pulmonary emphysema from X-ray CT: trainee reproducibility and accuracy. | Owrangi AM et al. | โ | 2013 | โ |
| The association of adiponectin with computed tomography phenotypes in chronic obstructive pulmonary disease. | Carolan BJ et al. | โ | 2013 | โ |
| A combined pulmonary-radiology workshop for visual evaluation of COPD: study design, chest CT findings and concordance with quantitative evaluation. | COPDGene CT Workshop Group et al. | โ | 2012 | โ |
| Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics. | Patel BB et al. | โ | 2012 | โ |
| Autoimmunity in chronic obstructive pulmonary disease: clinical and experimental evidence. | Kheradmand F et al. | โ | 2012 | โ |
| Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study. | Stewart JI et al. | โ | 2012 | โ |
| Automated texture-based quantification of centrilobular nodularity and centrilobular emphysema in chest CT images. | Ginsburg SB et al. | โ | 2012 | โ |
| AUTOMATIC AIRWAY ANALYSIS FOR GENOME-WIDE ASSOCIATION STUDIES IN COPD. | Estรฉpar RS et al. | โ | 2012 | โ |
| Chronic obstructive pulmonary disease: CT quantification of airways disease. | Hackx M et al. | โ | 2012 | โ |
| Chronic obstructive pulmonary disease history assessment in Spain: a multidimensional chronic obstructive pulmonary disease evaluation. Study methods and organization. | Lรณpez-Campos JL et al. | โ | 2012 | โ |
| Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. | Galbรกn CJ et al. | โ | 2012 | โ |
| Demographic, physiologic and radiographic characteristics of COPD patients taking chronic systemic corticosteroids. | Swift I et al. | โ | 2012 | โ |
| Early identification of small airways disease on lung cancer screening CT: comparison of current air trapping measures. | Mets OM et al. | โ | 2012 | โ |
| Genes and chronic obstructive pulmonary disease. | Foreman MG et al. | โ | 2012 | โ |
| Genome-wide association analysis of blood biomarkers in chronic obstructive pulmonary disease. | Kim DK et al. | โ | 2012 | โ |
| Interstitial lung abnormalities and reduced exercise capacity. | Doyle TJ et al. | โ | 2012 | โ |
| Normal range of emphysema and air trapping on CT in young men. | Mets OM et al. | โ | 2012 | โ |
| Pulmonary arterial enlargement and acute exacerbations of COPD. | Wells JM et al. | โ | 2012 | โ |
| Quantitative computed tomography in COPD: possibilities and limitations. | Mets OM et al. | โ | 2012 | โ |
| Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. | Zach JA et al. | โ | 2012 | โ |
| Reference standard and statistical model for intersite and temporal comparisons of CT attenuation in a multicenter quantitative lung study. | Sieren JP et al. | โ | 2012 | โ |
| Smoking and idiopathic pulmonary fibrosis. | Oh CK et al. | โ | 2012 | โ |
| The effect of iterative reconstruction on computed tomography assessment of emphysema, air trapping and airway dimensions. | Mets OM et al. | โ | 2012 | โ |
| The EvA study: aims and strategy. | Ziegler-Heitbrock L et al. | โ | 2012 | โ |
| Variation in quantitative CT air trapping in heavy smokers on repeat CT examinations. | Mets OM et al. | โ | 2012 | โ |